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1. 
OXYGEN THERAPY IN THE NEWBORN 
1.1 
INTRODUCTION 
Respiratory problems are particularly frequent in neonatal in-
tensive care. Impaired gas exchange in the lung together with 
disturbed breathing patterns are characteristic of respiratory 
distress in newborns. The result is often that the newborn will 
have difficulty in maintaining normal blood gas levels. The 
situation may be worsened if fetal circulatory pathways persist. 
Failure of the foramen ovale or the ductus arteriosus to close 
(right to left shunt) causes admixture of venous blood to the 
systemic arterial circulation and inadequate oxygen supply by 
the blood, leading to hypoxia. 
Administration of increased oxygen concentrations by the inspi-
ratory air is a vital part of neonatal intensive care; however, 
it is not without risks. The evolution of the knowledge con-
cerning the risks of hypoxia or hyperoxia has considerably in-
fluenced the oxygen therapy in the newborn during the last 35 
years (Klaus and Meyer, 1966; Roberton et al., 1968; Northway 
and Rosan, 1969). In the early 1940,s, with the improvement of 
incubator technology high oxygen concentrations could be main-
tained in the inspiratory path. In 1942, Wilson et al. observed 
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that periodic breathing in the newborn could be prevented and 
regular respiration restored by increasing the oxygen concen­
tration in the incubator. High oxygen concentrations were then 
recommended and often used during the next 10 years. In the 
early 1950's observations in several hospitals demonstrated 
that lesions of the retina were often associated with oxygen 
therapy (Patz et al., 1952; Lanman et al., 1954; Patz, 1957). 
As a consequence, for newborns the oxygen concentration in 
the ambient air was generally restricted to approximately 
40% (Lanman et al., 1954; Roberton et al., 196Θ). An even more 
extreme approach was that of S]ostedt and Rooth (1957) and 
Rooth et al. (1966) who treated newborns in incubators with 
only 15% oxygen, i.e., in an atmosphere where the oxygen 
tension was maintained between that of the intrauterine level 
and air. 
Actually, the trend in oxygen therapy for the newborn is to­
wards a more flexible use of this tool. The main concern of 
the clinician today is to have a reliable method for monitoring 
the oxygenation in the newborn in order to avoid the risks re­
lated to hypoxia and hyperoxia. 
1.2 
RISKS RELATED TO HYPOXIA 
In general, the symptoms associated with hypoxia mostly depend 
upon the rapidity with which the hypoxic state develops and 
the degree of hypoxia. The cause of hypoxia is important for the 
choice of the method of treatment (Riley, 1966; Due, 1971). 
All cells and tissues in the body are affected to some degree 
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by hypoxia, but cerebral damage is one of the main risks. Se-
veral studies have stressed the vulnerability of the neonatal 
brain to lack of oxygen (Van Liere, 1942; Avery and Fletcher, 
1974). Indeed, functional damage may occur if the arterial pO-
remains under a certain "critical level" for some time. This 
"critical level", which defines the tolerance to hypoxia, changes 
considerably during the first days of life. In the adult, accor-
ding to Noell and Schneider, the vital functions of the central 
nervous system may become deficient if the arterial pO- remains 
below 30 to 35 mm Hg. This "critical level" is much lower in 
the fetus, since the normal p0_ of fetal capillary blood during 
delivery has been reported to be between 15 and 25 mm Hg for 
short periods of time (Saling, 1966; Hickl, 1968; Berg and 
Saling, 1971; Walker et al., 1971; Bellée and Schönjahn, 1975). 
It must be noted that hypoxia is better tolerated by young 
than by adult animals which seems, at least in part, due to a 
greater tolerance of the central nervous system for low oxygen 
because of the increased capability for anaerobic glycolysis in 
the newborn (Selkurt, 1966; Prod'hom, 1972, Avery and Fletcher, 
1974). The precise evolution of the "critical arterial pO," during 
the first hours of life is not exactly known but new techniques 
for continuous pO- monitoring during and after delivery hopeful-
ly will help the perinatologist to obtain more information on the 
physiological aspects of this problem. 
1.3 
RISKS RELATED TO HYPEROXIA. OXYGEN TOXICITY 
"Perhaps, we may also infer from these experiments, that though 
pure dephlogisticated air might be very useful as a medicine, 
it might not be so proper for us in the usual healthy state of 
the body: for as a candle burns out much faster in dephlogisti-
cated than in common air, so we might, as may be said, live 
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out too fast, and the animal powers be too soon exhausted m 
this pure kind of air ..." 
Priestley thus guessed, 200 years ago, the toxic properties 
of oxygen. Administration of high oxygen concentrations has 
permitted survival of many newborns doomed otherwise. However, 
if oxygen may be thought of as a drug, its administration in-
volves risks as any other drug therapy. 
In the newborn, the retina, lung, brain and the red cell are 
particularly vulnerable to prolonged high oxygen levels (Klaus 
and Meyer, 1966). 
The lesions produced by oxygen in the immature retina are 
proportional to the concentration of oxygen administered and 
the duration of exposure, and inversely proportional to the 
degree of vascularization of the retina. The effects of oxygen 
may be divided into three stages: at first vasoconstriction 
occurs in the retina; subsequently, there are extravasation 
of blood and hemorrhages; eventually these hemorrhages are 
organized by fibrosis and new vessels proliferate in the retina, 
resulting in possible retraction and detachment of the retina 
(Ashton et al., 1954; Lanman et al., 1954; Patz, 1957; Patz, 
1969; Piorog and Ferrara, 1971). This type of lesions was first 
identified by Terry (1942) who called it "retrolental fibro-
plasia" . 
The critical level of arterial p02 which should not be exceeded 
in order to avoid the risks of retrolental fibroplasia is not 
well defined. However, suggestions and recommendations concer-
ning these limits have been given by several authors. According 
to Patz (1969), arterial p02 values between 80 and 100 mm Hg 
are safe for the retina, but a pO, of 300 mm Hg or more is cer-
tainly harmful. For Klaus and Meyer (1966) it is essential not 
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to allow the arterial pC^ to be maintained above 160 mm Hg for 
any prolonged period of time. 
Prod'hom (1972) and Vaughan et al. (1971) recommend to keep 
the arterial p0 2 lower than 100 mm Hg. Roberton et al. (1968) 
propose to maintain the рО^ of the abdominal aorta below 90 mm 
Hg. This should prevent the pO, in the retina from reaching the 
probable danger level of 160 mm Hg in the presence of nght-to-
left shunts through the ductus arteriosus. 
Molecular oxygen interferes with a wide variety of cellular 
functions and continued exposure to high oxygen concentrations 
may also injure pulmonary tissue. Progressive respiratory di­
stress occurs in the lungs associated with pulmonary edema, 
atelectasis, thickening of alveolar basement membrane, and 
fibrosis. The term "bronchopulmonary dysplasia" is applied to 
this chronic lung disorder (Northway and Rosan, 1969; Kafer, 
1971? Pierog and Ferrara, 1971; Usher, 1973; Avery and Fletcher, 
1974). Safe limits for the administration of oxygen to possibly 
prevent these pulmonary tissue lesions have not been established 
up to now, in part because of the individually different sus­
ceptibility to oxygen (Avery and Fletcher, 1974). 
High oxygen concentration decreases cerebral blood flow in the 
human adult but the effects of hyperoxia in the newborn are 
unknown (Lambertsen et al., 1953; Klaus and Meyer, 1966). 
Studies in the human adult have demonstrated an increased rate 
of red cell destruction when adult men are placed in an oxygen 
environment of more than 378 mm Hg for a prolonged period of 
time (Helvey, 1963). 
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1.4 
CONCLUSION 
One of the main concerns of the clinician is to avoid in the 
newborn the risks of hypoxia and hyperoxia. Oxygen therapy and 
any type of artificial ventilation should therefore be admini­
stered together with regular monitoring of the oxygenation of 
the newborn. For this purpose the most suitable parameter is 
the oxygen partial pressure of the arterial blood = ρ 0, (see 
also § 2.1) (Boston et al., 1966; Klaus and Meyer, 1966; Koch 
and Wendel, 1967; Roberton et al., 1968; Banister, 1969; Duc, 
1971; Strauss et al., 1972; Driscoll and Behrman, 1973; Rolfe 
and Eng, 1975). 
Recommendations concerning the optimal ρ 0^ range are given by 
several authors. For Driscoll and Behrman (1973) the ρ 0 7 should 
be maintained between 50 and 70 mm Hg, for Vaughan et al. (1971) 
and Glasgow et al. (1972) between 60 and 80 mm Hg, and for Rober­
ton et al. (1968) between 60 and 90 mm Hg. According to Usher 
(1973) premature newborns with respiratory distress syndrome 
have a better prognosis when oxygen therapy is adjusted to main­
tain the arterial pO^ at 40 rather than SO nun Hg. 
These values are not valid during the first hours of life. 
Indeed according to the measurements of Beutnagel et al. (1972) 
the normal ρ 0^ rises from 34 mm Hg 2 minutes after birth to r
a 2 
59 mm Hg at 11 minutes. In their study Roberton et al. (1968) 
reported an increase from 69 mm Hg 6 hours after birth to 
90 mm Hg at 48 hours. 
These values are given for the pO, of the lower abdominal aorta. 
Aortic ρ 0^ before the entrance of the ductal shunt blood and, 
'a 2 
therefore, the retinal pO, may differ considerably from the 
ρ 0,. of the abdominal aortic blood after the admixture of shunt 
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blood from the ductus arteriosus. The site of blood sampling 
for pOj measurement,or of oxygen monitoring may therefore play 
an important role. 
It is our purpose to describe, after a brief survey of the 
various invasive methods presently available for oxygen moni-
toring in the newborn, the technical, physiological and clini-
cal aspects of a non-invasive method for the continuous moni-
toring of the oxygenation in the newborn by sensors attached 
to the surface of the skin. 
16 
2. 
OXYGEN MONITORING IN THE NEWBORN 
2.1 
INTRODUCTION 
Several review articles concerning principles and methodology 
of blood gas analysis are available in the literature (Wilson 
and Laver, 1972, Adams et al., 1968; Morgan, 1968; Severinghaus, 
1968; Hamilton, 1969; Good, 1972; Adams and Hahn, 1973). There-
fore we will only briefly discuss the various methods in view 
of their applicability to oxygen monitoring m the newborn. 
It is perhaps important to mention first that blood oxygen can 
be expressed in several ways: Oxygen partial pressure (pO,) in 
nun Hg, oxygen saturation (SQ ) m per cent and oxygen content 
(CQ,) in vol. per cent. The p0 2 provides a measure of the 
"driving force" which promotes diffusion of O, across membranes 
and into cells. The oxygen saturation of blood expresses the 
relationship between the actual amount of O, bound to hemoglo-
bin at a given pO, and the capacity of the same blood. 
The oxygen content of whole blood represents the sum of the 
0- bound to hemoglobin plus the amount of 0- which is dissolved 
in the blood at the actual pO^. 
Thus we distinguish between three main types of oxygen de-
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terminations in the blood. When we talk about oxygen levels 
we always refer to arterial blood or to arteriallzed capillary 
blood. Indeed only arterial blood gases reflect the ability 
of the pulmonary system to add 0 2 to the blood and to remove 
CO, in response to the demands imposed upon the system. 
2.2 
DETERMINATION OF THE OXYGEN SATURATION 
The flat slope of the oxyhemoglobin dissociation curve at an 
elevated ρ 0. (higher than 90 to 100 mm Hg) makes oxygen satu­
ration an unreliable parameter to monitor hyperoxia (Kramer, 
1960). In contrast, because of the steep sigmoid relationship 
between oxygen saturation and oxygen partial pressure, the 
measurement of the oxygen saturation is potentially more 
accurate at low levels of oxygenation than ρ 0_ measurements 
(Due, 1971; Rolfe and Eng, 1975). The most interesting tech­
niques for measuring oxygen saturation are the fiber-optic 
systems using either a flow-through cuvette, an intravascular 
catheter or an earpiece (Enson et al. 1962; Polanyi and Hehir, 
1962; Sekelj et al., 1971; Wiedmeier et al., 1971; Electronics, 
1974; Merrick, 1975). The latter allows the non-invasive de­
termination of the oxygen saturation in arterialized capillary 
blood. 
2.3 
DETERMINATION OF THE OXYGEN CONTENT 
This parameter is subject to similar limitations as the oxygen 
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saturation for monitoring hyperoxia. Moreover the standard 
procedure, the Van Slyke mancmetric technique (Van Slyke and 
Neill, 1924), is rather time-consuming and cannot be used for 
continuous monitoring. Thus this method is not routinely used 
for oxygen monitoring m the newborn. 
However, several attempts have been made to develop simpler 
techniques by using an oxygen electrode (Awad and Winzler, 
1961; Laver et al., 1965). More recently, a galvanic cell 
system, using a 20 μΐ blood sample, has been made available 
commercially (Selman et al., 1975). 
2.4 
DETERMINATION OF THE OXYGEN PARTIAL PRESSURE 
As mentioned previously (§ 1.4) the most suitable parameter for 
monitoring the oxygenation of the newborn in hypo-, normo- and 
hyperoxia is the oxygen partial pressure of the arterial blood 
= ρ Oy (Boston et al., 1966; Klaus and Meyer, 1966; Koch and 
Wendel, 1967; Roberton et al., 1968; Banister, 1969; Duc, 1971; 
Strauss et al., 1972; Driscoll and Behrman, 1973; Rolfe and 
Eng, 1975). 
Various direct and indirect methods of ρ 0_ determination have 
'a 2 
been used: 
- discrete ρ О measurement by arterial blood sampling from 
either an indwelling umbilical artery catheter or from 
peripheral arteries 
- discrete pO, measurement by sampling arterialized capillary 
blood 
- continuous intra-artenal pO, monitoring by means of a 
catheter-tip transducer 
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- continuous monitoring of the cutaneous pO, by skin sensors 
2.4.1 
Discrete ρ 0_ measurement by arterial blood sampling from 
an indwelling umbilical catheter 
The introduction, in the late fifties, of umbilical artery 
catheterization together with relatively rapid in vitro methods 
for blood gas measurements represented a significant advance 
in neonatal intensive care. 
This method allows to take arterial blood samples in the ab­
dominal aorta without too much difficulty and, at least theo­
retically, as often as needed. Moreover, the catheter can be 
used to administer fluids to the newborn. 
These are the two main advantages of this method which, how­
ever, has several drawbacks (Ray, 1964; Mortensen, 1967; Cochran 
et al., 1968; Banister, 1969; James, 1969; Van Leeuwen and 
Patney, 1969; Wigger et al., 1970; Pierog and Ferrara, 1971; 
Glasgow et al., 1972): 
- risk of thrombus formation, infection, hemorrhage, vascular 
and peritoneal perforation 
- insertion of such a catheter requires a skilled staff 
- insertion may occasionnally be impossible, especially if not 
performed shortly after birth 
- risk of thrombus formation within the catheter, even after 
short periods of time; oxygen monitoring by this method is 
then no longer possible 
- frequent blood sampling is not possible because of unacceptable 
blood loss; thus the short-term, clinically significant ρ О, 
changes will not always be detected soon enough to allow an 
optimum control of the oxygenation in the newborn 
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- in the presence of right-to-left shunts through the ductus 
arteriosus the abdominal aorta ρ 0, may differ considerably 
from the retinal pO, 
- results are not immediately available 
- The accuracy of ρ О- measurements with Blood Gas Analyzers 
depends upon a multitude of factors including the technique 
of collection and handling of the blood samples, the tempe­
rature of the patient, the calibration of the electrode and 
its physical properties. We will not discuss this problem in 
detail,which has been reviewed by several authors (Grant and 
Barber, 1966; Rhodes and Moser, 1966; Mac Intyre et al., 
1968; Rogers et al., 1968; Severinghaus and Bradley, 1969; 
Isherwood et al., 1972; Wilson and Laver, 1972; Spicer, 1973). 
However, since the p0_ determination with a Blood Gas Analyzer 
is presently the standard reference method, every new method 
of pO, measurement will be compared to it. Therefore some 
additional data concerning this problem will be given within 
the frame of the discussion about the reliability of the 
cutaneous pO, measurement (§ 4.2). 
2.4.2 
Discrete ρ 0- measurement by arterial blood sampling from 
peripheral arteries 
For direct blood sampling, the following arteries are suitable: 
the brachial, radial, femoral, and temporal arteries. 
This method has several drawbacks. It requires considerable 
practice and neither of these small arteries allows repeated 
sampling from a single puncture. Repeated punctures may be 
contraindicated or technically impossible (Ray, 1964; Mortensen, 
1967; Cochran et al., 1968; Siggaard-Andersen, 1968; Van Leeuwen 
and Patney, 1969). Therefore, it is not appropriate for long-
term oxygen monitoring. Moreover, during sampling from peripheral 
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arteries, the infant may start crying, thus increasing venti­
lation which will change the blood gas values as compared with 
the original conditions (Pierog and Ferrara, 1971). This compli­
cation may be prevented by inserting a sampling catheter into 
a peripheral artery and withdrawing blood only after the infant 
has quieted down. 
However this method offers two advantages: 
- the risks related to umbilical artery catheterization can 
be avoided 
- in the presence of right-to-left shunts through the ductus 
arteriosus sampling from the temporal or right radial arteries 
provides a much better estimate of the retinal pO, than the 
ρ О. of the abdominal aorta. r
a 2 
Several attempts to measure ρ О^ on line by using peripheral 
arterial blood have been made. Flow-through cuvette systems 
which utilize an artificial arterio-venous shunt and allow 
real-time blood gas measurements in adults have been described 
in the literature (Meyer et al., 1961} Sugioka, 1967; Buzza et 
al., 1970). However, this method which requires heparimzation 
of the blood and sterilization of the sensor, is rarely used 
in clinical medicine and, as far as we know, has not been 
applied to the newborn. 
Another approach has been chosen by Veasy et al. (1971) who 
described a computerized, automated system for blood gas 
analysis designed to monitor critically-ill newborns. This 
technique seems cumbersome and will lead to unacceptable blood 
loss from the newborn. 
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2.4.3 
Discrete pO, measurement by artenalized capillary blood 
sampling 
In order to overcome the disadvantages of arterial blood samp­
ling mentioned above, alternative methods were investigated. 
The development of micromethods, allowing the determination 
of blood gas with less than 50 μΐ of blood, has brought the 
hope that artenalized capillary blood could be used for 
measuring arterial oxygen tension. Several comparative studies 
have been performed but the results have been disappointing 
in the newborn. 
One of the main problems in the cutaneous pO^ measurement is 
the arterialization of the tissue underneath the sensor. It is 
therefore interesting to analyze in more detail the various 
arterialization techniques which have been used up to now. 
The reliability of using artenalized capillary blood for the 
measurement of ρ 0- depends on the age of the patient, the site 
a 2 
of capillary blood sampling and the technique of arterialization. 
At p0 2 levels below 200 mm Hg Koch (1968) m adults found a good 
correlation between ρ О, and pO-, in artenalized capillary blood 
obtained from the ear lobe. Arterialization of the ear lobe was 
achieved by massage with nicotinic acid during 5 minutes. In 
contrast, the correlation was poor when he used capillary blood 
obtained from the fingertip which had been warmed in water at 
45 С during 10 minutes. These results are in agreement with those 
of Forster et al. (1972), Mac Intyre et al. (1968) and Laughlin 
et al. (1964), the latter group having used an electrical heater 
for arterialization of the ear lobe. These good results obtained 
with artenalized capillary blood from the ear lobe may be 
due to special characteristics of the ear lobe such as only 
rudimental and inactive muscles, thus assuring a low rate of 0 9 
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consumption with consequently very low arterio-venous 0, 
difference. However, Mac Intyre et al. (1968) noted also that 
the correlation was best at "lower" oxygen tensions (p0_ below 
300 mm Hg), and Krekeler et al. (1971) who used Finalgon to 
arterialize the ear lobe, found a better correlation in hypo-
and normoxic than in the hyperoxic ranges. Spicer (1973) 
used blood samples from the ear lobe massaged for 3 minutes 
before sampling. They reported a reasonably good correlation 
except in patients with disturbed peripheral circulation such 
as in shock, pain, and anesthesia. This limitation of the 
method in adults has also been reported by others (Patz, 19 57; 
Laughlin et al.,1964; Koch, 1968). 
These relatively good results in adults have so far not been 
confirmed in newborns. 
Koch and Wendel (1967) found a poor correlation in normal new­
borns between abdominal aorta and artenalized capillary blood pO_ 
during the entire neonatal period (30 minutes to 6 days post 
partum). Arterialized capillary blood was obtained from a heel 
prick following a 5 - lO-minute-arterialization period in 
45 - 47 С water. As they noted, "discrepancies between arterial 
and capillary pO, were not unexpected since it is known that 
correlation is unsatisfactory even in healthy adults when 
capillary blood is sampled from the fingertip rather than the 
ear lobe". Bannister (1969) and Mountain and Campbell (1970) used 
capillary samples collected from the warmed heel in newborns 
with respiratory distress and found similar results. Unsatis­
factory correlation was also reported by Due and Cumarasmy (1974) 
between digital arteriolar and aortic pO-. 
However, better correlations, although with sometimes severe 
limitations, were reported by other authors. 
24 
Winquist and Stamm (1970) used t-\e histanine iontophoresis 
technique to arterialize the heel or the fingertip. In (presu-
mably) normal newborns they found a satisfactory correlation in 
the pOj range of 50 to 150 mm Hg up to 5 days of age. In ill 
newborns Glasgow et al. (1972) obtained arterialization by 
using a vasodilating cream applied to the heel for 15 to 20 
minutes. According to them "arterialization capillary sampling 
is a reliable means of assessing aortic p0 2 when the arteria-
lized capillary value is less than 60 mm Hg". This is evident-
ly a severe limitation of the method. Still more restrictive 
is Usher (1973) who found a good correlation between abdominal 
aorta and warmed heel capillary blood p0 2 only for pO- levels 
below 35 mm Hg. In contrast in the 50 - 60 mm Hg range, the 
arterial values were, on the average, 25 mm Hg higher than the 
capillary pO,. The difference may be 50 mm Hg or more in ex-
treme cases. Desai et al. (1967) who locally sprayed the scalp 
with ethyl chloride to create arterialization also found a good 
correlation in older newborns (5 days and more) between artena-
lized scalp pO- and temporal artery pO^; however, their study 
was limited to the hypoxic range. 
Although the ear lobe should theoretically be a preferred samp-
ling site because of its proximity to vital oxygen-sensitive 
areas such as the retina and the central nervous system (see 
§ 1.4 and 2.3.2), only few attempts have been made, very likely 
for practical reasons, to use capillary blood from the ear lobe 
in the newborn. 
Von Leupold et al. (1972) used Fmalgon to arterialize the ear 
lobe of 2 to 55-day-old newborns and found a relatively poor 
correlation in the normoxic range between temporal artery and 
capillary blood pO,. In newborns and infants Strauss et al. 
(1972 and 1973) performed pO, measurements in abdominal or 
thoracic aorta blood, arterialized capillary blood and arteria-
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lized tissue of the ear lobe. The latter parameter was moni­
tored continuously using a bare-wire oxygen electrode implanted 
in the ear lobe. Arterialization was obtained by heating the 
ear lobe to 41 С with an infrared lamp. A good correlation was 
found between arterial and capillary blood pO, in the range of 
35 to 160 mm Hg, and between capillary blood and tissue pO- in 
the range of 25 to 275 mm Hg. However, this technique, al­
though very interesting, seems too cumbersome according to its 
authors to be routinely used clinically. Moreover there is a 
risk of local complications from the inserted wire. 
Today the use of arterialized capillary blood for the measure­
ment of arterial oxygen tension in the newborn is generally 
no longer recommended to the clinician. 
2.4.4 
Continuous ρ Oj monitoring by means of a catheter-tip trans­
ducer 
As we mentioned previously (§ 2.4.1) the pO™ measurement by 
arterial blood sampling does not allow to detect short-term, 
clinically significant p0_ changes. Therefore there has long 
been a demand for methods capable of providing arterial blood 
gas data on a continuous basis without blood sampling. 
In recent years it has become possible to measure the intra­
vascular oxygen partial pressure continuously with the help 
of miniaturized sensors based on mass spectrometnc or ampero-
metric principles. Mass spectrometry has the advantage of per­
mitting the simultaneous determination of 0,, C0 2 and other 
gases (Woldring et al., 1966; Brantigan et al.,1970; Wald et 
al., 1970; Woldring, 1970; Key, 1975); however, this method 
appears to be too cumbersome - and up to now too costly - for 
routine use. The miniaturization of the Clark-type sensor for 
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the continuous monitoring of intravascular oxygen tension was 
first described by Kreuzer and Nessler (1958). Since then 
numerous constructions of miniaturized pO« sensors based on the 
ampcrometric principle have been described m the literature (Schu-
ier and Kreuzer, 1967; Kimmich and Kreuzer, 1969; Parker et al., 
1971; Neuman et al., 1971; Niedrach and Stoddard, 1972; Bicher 
et al., 1973; Busser et al., 1973; Harris and Nugent, 1973; 
Huch et al., 1973; Meldrum et al., 1973; Mindt, 1973; Huxtable 
and Fatt, 1974; Liu et al., 1974; Strauss et al., 1974; Eber-
hard, 1975 ¡Eden et al., 1975; Dodd, 1975; Jank et al., 1975; 
Soutter et al., 1975; Goeckenjan et al., to be published). 
The principal advantage of the continuous intravascular ρ О» 
monitoring system is the information provided in terms of real­
time changes in arterial oxygen tension. However, although the 
use of catheters in umbilical vessels may lead to improvements 
in the case of critically-ill newborns, its implantation 
can also create serious problems which are inherently connec­
ted with any indwelling umbilical catheter (Strauss et al., 
1974) (see § 2.4.1). 
Moreover the problems concerning, e.g., the calibration, 
linearity and stability of these sensors and their incorpora­
tion into a double-lumen catheter to allow fluid infusion and 
withdrawal of arterial blood samples for pH and pCO, determi­
nations have not always been resolved satisfactorily. 
Thus, because of the complexity of the designs as well as the 
difficulties and the risks inherent m their practical use, 
these sensors have so far not been widely accepted for clini­
cal routine application. 
We have developed such an intravascular pO-, catheter, mainly 
for ρ О. monitoring in adults where the limitations of the 
27 
method are less important. More details concerning the characte­
ristics such a sensor should have for clinical routine use are 
given in Appendix 1. We have used it to perform continuous 
comparative measurements between ρ 0_ and cutaneous pO, (see 
§ 4.3). 
2.5 
CONCLUSION 
In this survey of the various methods used for the oxygen 
monitoring in the newborn we have seen that the most suitable 
parameter is the arterial blood pO,. This is of considerable 
importance in preventing the deleterious effects of both hypo-
and hyperoxygenation, such as damage to brain, eyes and lungs. 
We have also seen that continuous monitoring is preferable 
since pathological changes and toxic levels of pO, can be re­
cognized immediately. Furthermore, information of prognostic 
value may be obtained from observing the trend of oxygenation 
in the neonate. Because of the limitations inherent in the 
presently available methods there is a demand for a continuous 
p0 2 monitoring method which is practical, reliable and appli­
cable without undue risk. 
A description of a non-invasive method for the continuous 
measurement of the pO, by sensors applied to the surface of the 
skin is given in the following sections. The oxygen partial 
pressure obtained by this sensor reflects the oxygen availabi­
lity at the measuring site which, under certain operational 
conditions, correlates with the pO- of arterial blood. 
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3. 
CONTINUOUS MONITORING OF CUTANEOUS P 0 9 BY SKIN SENSORS 
3.1 
INTRODUCTION 
The process commonly called cutaneous respiration has been 
known in man for a long time. Already in 1851 von Gerlach 
studied the oxygen diffusion through the human skin. In 1929 
Shaw et al. showed that the principal factor influencing the 
cutaneous respiration is the temperature of the air in contact 
with the skin. The phenomenon that oxygen diffuses readily 
through body tissues and skin has been utilized by Baumberger 
and Goodfriend (1951) to determine arterial pO-. They immersed 
a finger into an electrolyte solution heated to 45 C, and 
demonstrated that within 15 - 60 m m the p0_ of the solution was 
equilibrated with that of the arterial blood. The pO, of the 
solution was determined at appropriate intervals by means of the 
Polarographie method. The results of Baumberger were confirmed 
by Rooth et al. (1957) who tried to measure the p02 of newborn 
infants continuously by placing their feet in warm water and 
measuring the pO, of the water after equilibration. However, the 
oxygen consumption of their sensor was too great compared to the 
diffusion capacity of the skin and it was therefore not possible 
to obtain cutaneous p0_ values close to the arterial values (Rooth, 
1975). Moreover the method was too cumbersome for clinical use. At 
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the same time the Clark electrode became available and these 
transcutaneous studies were abandoned. 
Oxygen skin sensors that are in direct contact with the skin 
surface were first described by Evans and Naylor (1967a, 1967b). 
The oxygen tension measured under steady-state conditions on 
the surface of non-arterialized adult skin was less than 3.5 mm 
Hg when the subject was breathing air or oxygen. On arteria-
lized adult skin the oxygen tension rose to about 30 mm Hg 
when breathing air and to about 350 mm Hg when breathing 
oxygen. Local arterialization of the skin was produced in se­
veral ways, including mechanical stripping to remove the stratum 
corneum and treatment of the skin with vasodilating substances 
(thurfyl nicotinate), histamine iontophoresis, or irradiation 
with UV light. They also demonstrated the influence of respira­
tory maneuvers and arterial occlusion on the cutaneous oxygen 
tension but no direct relation with arterial pO- was reported 
(Naylor and Evans, 196Θ) . 
Later Huch and Lubbers (1969) reported the first pO- measurements 
by surface sensors on the scalp of normal newborns. They measured 
a pO, of 37 + 9 mm Hg on the non-arterialized scalp and of 68 + 7 
mm Hg on the scalp arterialized by local treatment with a vasodi­
lating substance (nicotinic acid derivative). Their experiments 
showed that pO- values relatively close to the arterial level may 
be obtained if arterialization of the tissue adjacent to the 
sensor is induced. 
However, none of the methods which were proposed to arterialize 
the skin and which are similar to those used to arterialize the 
capillary blood (see § 2.4.3), produce a constant effect over 
a longer period of time. In addition they are hardly suitable 
for routine use in practical medicine. 
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As an improvement of these methods the application of heat 
stimulation by directly heating the sensors to achieve constant 
arterialization over longer time periods was proposed by us 
(Eberhard et al., 1970, 1972) and by Huch et al. (1972). 
3.2 
AMPEROMETRIC p0 2 DETERMINATION 
The Clark principle (1956) of the pO^ measurement utilized 
here is based on redox reactions in a cell consisting of a 
noble-metal cathode and a reference anode which are electri-
cally connected by an electrolyte and covered with an oxygen-
permeable, hydrophobic membrane. When a potential is applied, 
oxygen is reduced at the cathode and a current is produced 
which can be measured. By slowly changing the potential 
applied to the cathode to more negative values the current in-
creases producing a current-voltage curve or polarogram with 
a limiting current plateau over a certain voltage range (Fig. 1). 
When the potential is adjusted to this plateau region the 
current measured between both electrodes is proportional to 
the pu- in the adjacent medium, provided the diffusion of oxy-
gen through the membrane limits the rate of oxygen transport 
to the cathode. 
Contrary to conventional Clark-type sensors, where the cathode 
diameter is kept small, we use a large-size cathode (diameter 
4 mm) to obtain an average pO, value over a sufficiently large 
skin area (Eberhard et al., 1973). The permeability of the 
membrane for oxygen has to be kept low to prevent disturbance of 
current 
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cathode potential vs. Ag/AgCI 
Fig. i . Stationary current voltage curve of рОг sensor 
the oxygen profile in the cutaneous tissue as a result of the 
oxygen consumption of the sensor. In our case Mylarviy membranes 
(polyterephtalate, Dupont) with a thickness of 6 pm are used. 
The reasons for this choice will be discussed in more detail 
in the next sections. At first the characteristics of the 
sensor will be described. 
3.3 
SENSOR CHARACTERISTICS 
A schematic diagram of the sensor is shown in Fig. 2. The 
following criteria have been taken into account for selecting 
the elements of this sensor. 
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1) skin 
2) adhesive ring 
3) contact fluid 
4) membrane 
5) electrolyte 
6) cathode 
7) anode 
8) membrane retainer ring 
9) heating element 
10) thermistors 
11) encapsulation 
12) encapsulation 
Fig. 2. Cross-section of cutaneous oxygen sensor 
Fig. 3. Cutaneous oxygen sensor 
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3.3.1 
External form 
The requirements of this sensor were met as follows: 
- sturdy: all components are embedded in an epoxy body. 
- easy to prepare: the membrane (4) is secured with a snap-on 
ring (8). 
- easy to attach to the skin: a self-adhesive ring (2) is used. 
In this way the pressure of the sensor against the skin is 
extremely low and does not cause any compression of the blood 
vessels underneath the sensor. 
- air-tight fit: the shape of the membrane retainer ring (8) 
was chosen such that it prevents diffusion of oxygen from 
the surrounding air to the cathode. The tightness of the 
seal on hairless skin was tested by blowing pure oxygen 
against the sensor. This did not cause any alteration of the 
measured signal. 
- not too cumbersome for the patient: the sensor is relatively 
flat, the cable outlet is at skin level and parallel to the 
skin surface. The sensor has the following dimensions (Fig. 3): 
diameter 20 mm, thickness 6 mm, and weight 3 g. 
3.3.2 
Cathode (6) 
A large-surface gold cathode (4 mm diameter) is used in order 
to obtain an average pO, value over a sufficiently large skin 
area. 
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3.3.3 
Anode (7) 
A large-surface Ag/AqCl reference electrode is used in order 
to avoid polarization effects (Janz, 1961). 
3.3.4 
Sensor heating system 
It consists of a heating element (9) near the cathode and two 
thermistors (10) inside the cathode for temperature control. 
The stability of the membrane temperature (over the cathode) 
and, therefore, the permeability coefficient of the membrane 
for oxygen thus is optimally controlled. 
The heating system has the following characteristics: 
- sensor heating resistor : 100 ohm 
- sensor thermistors, trimmed: 5600 ohm at 44 С 
- sensor temperature : 44.0 С + 0.2 С for clinical 
routine application. 
The choice of the specific sensor temperature partly depends on 
the type of clinical application. In general, a sensor tempera­
ture of 44 С is used. 
3.3.5 
Electrolyte 
A buffered (pH 8) hygroscopic solution is used as electrolyte, 
which guarantees the stability of the sensor at 440C for several 
days. 
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3.3.6 
In vitro characteristics of the pO- sensor 
The polarogram and the calibration line of the pO- sensor in 
the gas phase are shown in Fig. 4. The sensor is heated to 
44 C. The oxygen reduction plateau is broad and horizontal over 
a wide voltage range (approximately 600 mV) at oxygen levels 
between О and 100%. The calibration line is linear between 
0 and 100% От 
Fig. 4. 
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For our pO_ measurements the gold cathode is polarized 
with - 900 mV to the Ag/AgCI anode. At this potential the 
current in air of the sensor covered with a 6 μπι Mylar membrane 
and heated to 44 С is as follows: 
current 
expressed per mm Hg 
ι = 350 nA 
I = 2.33 nA/mm Hg 
2 S ¿. 
expr. per mn Hg and run cathode I = 0.19 nA/mm Hg mm cathode 
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In an atmosphere completely free of oxyqen, e.g. in pure 
nitrogen, the current is: 
current 
2 
expressed per mm cathode 
I < 9 nA 
о 
с 2 
І
ь
 < 0.72 пА/ішп cathode 
о 
The reproducibility of the current of an individual sensor 
with repeated use is 4 % when the sensor is freshly prepared 
(see § 3.7) before each application. 
The drift of the current of the sensor when placed in a cali­
bration chamber with air saturated with water vapor is shown 
m Fig. 5. On the average this drift is below 6 % / 12 hours 
after elapse of the stabilization period. 
F i g . 
0 1 2 4 6 θ 10 12 16 20 24 
Time (h) after application of the potential to the sensor 
5. Stability of cutaneous oxygen sensor in air saturated with 
water vapor 
The temperature dependence of the sensor current is 4 %/ С 
at 44 С when determined m air saturated with water vapor. 
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There is no measurable interference by CO. at a concentration of 
7 % C0 2 in the gas phase. 
The data concerning the response time of the sensor and the 
frequency characteristic of the membrane will be discussed 
separately (§ 3.5). 
3.3.7 
Oxygen consumption of the sensor 
According to the over-all cathode reaction in an alkaline 
solution, 
0 2 + 2 H 20 + 4 e" -·· 4 0H~ 
the reduction of one mol О- requires 4 F coulombs (Ives, 1961). 
Therefore, the 0^ consumption of the sensor is given by: 
q = j 3^; mol o 2/s 
where i = sensor current, A 
F = Faraday constant, A·s 
In our case the following value has been calculated by 
measuring the sensor current in air: 
O, consumption q 
expressed per mm Hg Q 
2 
expr. per mm Hg and mm cathode Q 
= 8 . 8 6 - 1 0 μιηοΐ О, / s 
= 5 . 7 5 Ί Ο pmol О- / s-rnm Hg 
= 0.46-10~9pmol 0 2 / 
2 
s-mm Hg·mm cathode 
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3.3.θ 
Permeability coefficient (Ρ ) of the Mylar membrane for oxygen 
Some values from the literature for P.. at various temperatures 
M r 
are listed in Table 1. 
Table 1: Permeability coefficient (P ) of Mylar membrane 
Temperature 
<
0C) 
25 
25 
30 
37 
44 
v-
10 
(ml 02/cm-s
,
atm) 
4.38 
5.02 
3.42 
4.36 
4.5 
Reference 
Dupont 
Schuler (1966) 
Polymer Handbook (1967) 
Severinghaus (1968) 
Eberhard (1976) 
The value for P„ at 440C given m Table 1, P.. = 4.5-10 ml 
M M 
O./cm-s-atm, has been determined with equation (13) (§ 3.4.3) 
from measurements of the sensor current m air, the value of 
pO, being calculated according to equation (31) (§ 3.7). 
3.4 
OXYGEN PROFILE IN THE VICINITY OF THE CATHODE 
As mentioned previously (§ 3.2) our skin sensor uses a large 
cathode (diameter 4 mm) in contrast to conventional Clark-type 
oxygen sensors where the cathode diameter is kept small. This 
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is done to obtain an average pO- value over a sufficiently 
large skin area. The permeability of the membrane for oxygen 
must therefore be kept low to avoid disturbing the oxygen 
profile in the skin as a result of the oxygen consumption of 
the sensor. 
In the following we propose a model in order to determine the 
oxygen profile in the vicinity of the cathode. It will be out­
lined after having briefly described some properties of the skin. 
3.4.1 
Structure of the skin 
The skin essentially consists of two different layers:(Fig. 6): 
(1) the epidermis, an avascular superficial layer of stratified 
epithelium that develops from ectoderm, 20 to 1400 jam in thick­
ness, and underneath (2) the dermis, a layer of connective 
tissue, 100 to 400 μπι m thickness, which lies on the subcuta­
neous tissue, a layer of fatty areolar tissue (Rushmer et al., 
1966; Guyton, 1968; O'Rahilly, 1969; Scheuplein et al., 1971). 
The skin has a profuse blood supply far in excess of its meta­
bolic needs, which is important for temperature regulation. The 
subcutaneous arteries form a network in the subcutaneous tissue. 
From these a subpapillary plexus is derived which is specially 
dense in the upper dermis of the newborn skin (Ryan, 1973). 
Capillary loops m the dermal papillae arise from the 
subpapillary plexus, and from these loops the avascular epi­
dermis is bathed in tissue fluid. 
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• epidermis 
tissue 
Fig . 6. Schematic representation of the skin 
3.4.2 
Effect of heat on various skin parameters 
The active vasodilatation of the cutaneous vessels in response 
to increasing ambient temperature is a well known phenomenon 
which has been described by several authors (Greenfield, 1963j 
Malkinson, 1964; Guyton, 1968; Fox, 1974; Montagna and 
Parakkal, 1974) . According to Hertzman (1961) maximal perfusion 
rates aro found at 45 C. Higher levels of blood flow were not 
noted when the temperature was increased to 50 C. This limit 
to cutaneous vasodilatation appears to be the same over the 
whole body, except for the palm, the sole of the foot and the 
face. An additional advantage of thermal arterialization is the 
fact that the blood flow in the extremities increases more 
than the oxygen consumption (Linhart and Prerovsky, 1962). The 
percentage of utilized oxygen thus falls with increasing tempe-
rature/and it is reasonable to assume that it is possible to 
create an optimum arterialization of the cutaneous tissue by 
heating it effectively to a temperature of about 4 5 C. 
According to Malkinson (1964) increased blood flow is also 
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an important factor in percutaneous absorption. "The group 
of compounds for which hyperemia probably plays the most signi­
ficant role is that of gases and vapours, to which the skin, 
like most other tissues is highly permeable". 
The temperature increase also has an influence on the permeabi­
lity coefficient of the cutaneous tissue for oxygen (the per­
meability increases with increasing temperature)and on the 
blood oxygen tension. According to various authors (Handbook 
of Physiology, Respiration, 1965) the effect of the temperature 
between 13 С and 38 С on the blood oxygen tension (at a con­
stant pH) over the entire saturation range may be described by 
the relation: 
Δ log p0 2 = 0.0234 Δ Τ 
which gives a temperature coefficient of approx. 5% per С 
(Bradley et al., 1956} Gleichmann and Lubbers, 1960). 
3.4.3 
Simplified model of the cutaneous tissue 
In order to determine the oxygen profile in the vicinity of 
the cathode let us consider the transport and metabolism of 
oxygen in the cutaneous tissue. The equation of continuity in 
terms of the oxygen tension in tissue is as follows (Schuier, 
1966; Lih, 1975): 
oc -
(1) -s-r = D div grad с - v-grad с - Q 
where с = oxygen concentration 
D = oxygen diffusion coefficient 
ν = convective velocity of the medium in 
which oxygen is dissolved 
Q = rate of oxygen consumption 
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This equation of continuity involving СЦ consumption and O, 
transport by diffusion and convection is a form of the second 
law of Pick. 
In practice it is relatively difficult to determine the oxygen 
profile from this equation because the quantitative values of 
most of the parameters for the individual layers of the 
arterialized cutaneous tissue are not known. 
We will consider a simplified model which permits an effective 
treatment of the problem without loss of generality (Fig. 7). 
p 0 2 Ρ 
Telectrolyte 
cathode 
m c 0 2 
membrane avascular cutaneous arterialized cutaneous 
tissue tissue 
Fig. 7. Oxygen profile in membrane and in tissue adjacent to sensor 
(a| Ideal case p O j gradient is limited to membrane 
lb) 6 μιτι Mylar membrane 
(c) 13μηι Teflon membrane 
It consists of an avascular cutaneous tissue layer adjacent 
to the arterialized cutaneous tissue in which the effect of 
oxygen diffusion to the cathode on the oxygen profile is assumed 
to be negligible. This is roughly the case when the "capilla-
rized" layer of the dermis (see § 3.4.1) has been effectively 
arterialized. This assumption is reasonable if one takes into 
account the previously described effect of heat on various skin 
parameters (see § 3.4.2). This hypothesis can also be justi­
fied a posteriori (sec below). 
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Further assumptions are: 
- cathode diameter > > d +d +d ,_ 
e m et 
(d = thickness according to Fig. 7) 
In our case: cathode diameter = 4000 um (large cathode area), 
d = 10 to 20 μια, d = 6 pn and d <: 400 um (estimation 
according to § 3.4.1). 
Therefore radial diffusion at the edges of the cathode 
can be neglected and the equation of continuity (1) may be 
used in one dimension only. 
- the oxygen tension at the cathode surface is zero. 
- the effect of the electrolyte layer on the oxygen profile is 
negligible, as may be seen from the following data and re­
ferring to an equation similar to (11) below: 
for the Mylar membrane: d = 6 urn 
m * 
Ρ = 4.5·10 ml 0_ / cm-s-atm (at 
m Ζ 
44 С) (own measurements) 
for the electrolyte: d = lo to 20 jim (own measurements) 
Ρ = P„ „ = 7.9·10~ ml 0, / cm-s-atm 
e H2O 2 
(at 44 C) (Handbook of Respira­
tion, 195Θ) 
- no oxygen consumption in the avascular cutaneous tissue layer 
- steady-state conditions 
3.4.4 
Oxygen profile in the vicinity of the cathode 
Under the conditions mentioned above the equation of continu­
ity (1) as applied to the membrane and the avascular cutaneous 
tissue layer becomes: 
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(2) Г-Ц = О Ъ
2 
Ò 2 ζ 
The О-, transport to the cathode occurs, in our case, by diffu­
sion through the membrane and the avascular cutaneous tissue 
layer, and the first law of Fick can be applied as follows: 
(3) J = - D If 
ζ ÖZ 
where J = diffusion current density of oxygen 
By using the relationships: 
(4) с = α p0 2 and (5) Ρ = ι D (Schuler, 1966) 
where α = oxygen solubility coefficient 
Ρ = oxygen permeability coefficient 
p09 = oxygen partial pressure 
the first and second laws of Fick become: 
àpO 
(6) J = - Ρ - r — and 
z oz 
Ъ
2
Р
о2 
The general solution of equation (7) is: 
(8) p02 (z) = Л + В z 
where A and В = constants 
The oxygen profile therefore is linear in the two layers. 
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The oxygen supply to the cathode, calculated with equation 
(6) and under the conditions that: 
(9) 
pO,(0 < ζ i d ) = 0 
p02(z > d e + d m + d c t) = p;0 2 
is given by 
(10) 
Ρ
 Ο
ο 
j = - Ρ qnç_2 
ζ m d 
m 
et 
P;02 " Pmc 02 
d
ct 
where p0 2 
p ; o 2 
Pmc02 
et 
et 
= oxygen partial pressure, mm Hg 
= arterialized cutaneous tissue pO,, mm Hg 
pO_ at the interface of membrane and 
avascular cutaneous tissue, mm Hg 
= permeability coefficient of the membrane 
for oxygen, ml 0-/cm-s-atm 
= permeability coefficient of the avascular 
cutaneous tissue for oxygen, ml 0_/cm-s-atm 
= thickness of the electrolyte layer, cm 
= thickness of the membrane, cm 
= thickness of the avascular cutaneous tissue 
layer, cm 
This allows to calculate ρ О.: 
r
mc 2 
(11) 
Ρ
 0
τ me 2 
Pa 02 
1 + 
Ρ d . 
m et 
m et 
Thus the oxygen profile, according to equations (8), (9) and 
(11), is given by: 
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(12) 
Ο ί ζ < d 
d ί ζ id +d 
e e m 
d +d $ ζ S d +d +d . 
e m e m e t 
d +d +d ^ ί ζ 
e m e t v 
p 0 2 = 0 
P 0 7 = P m .
0 
z - d 
2 ^mc 2 d 
z - ( d +d ) 
" m 
P 02=Pmc 02 +(Pa 02-Pmc 02) d ^ 
p02=p¿02 
As mentioned previously the current of the oxygen cathode is 
determined by the quantity of oxygen supplied by diffusion 
to the cathode per unit time. It is a linear function of the 
oxygen partial pressure over the surface of the membrane (in 
our case ρ 0 2 ) . The following current equation can be derived 
from the law of Faraday and the first law of Fick (Schuier and 
Kreuzer, 1967): 
(13) 
4 τ a F Ρ 
22400 
m 
Ρ
 Ο
ο me 2 
where ι = current, A 
a = sensor cathode radius, cm 
F = Faraday constant, A-s 
Substituting equation (11) into equation (13) yields: 
4 τ a 
(14) 
22400 
p ; 0 2 
ct 
ct 
According to equation (14) the current is limited by the 
diffusion of oxygen through the membrane only and thub is a 
measure of the arterializoc' cutareous tissue pO, if: 
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d d ^ 
(15) f » p^ 
m et 
When this condition is fulfilled the calculation of ρ О, from 
me 2 
equation (IO) gives the following approximation: 
ρ От = p'O-
*тс 2 ra 2 
The values for d , Ρ and Ρ . are known (see below). Within 
m m et 
the frame of the above-mentioned approximations of this model, 
the thickness of the avascular cutaneous tissue layer d . can be 
estimated with equation (14) from comparative in-vivo measure­
ments with sensors covered by different membranes such as 
Mylar 6 pm and Teflon 13 μτη, the latter having a much 
higher permeability coefficient for 0 2. Indeed the current of 
the sensor, with equation (14), is given by: 
Ana2 F p'
a
02 
(16) i = . . — with a Mylar (M) membrane 
d d . 
m et 
P M Ρ , 
m et 
and 
4 7Га2 F рМЭ2 
(17) i = 22400 "τ with a Teflon (T) membrane 
d d . 
m et 
P T Ρ ^  
m et 
Combining equations (17) and (16), we obtain: 
l ^ - i 
P ^ .T 
(18) d . ,T .M ,M et d i d 
m _m 
_T " .T „M 
Ρ ι Ρ 
m m 
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3.4.5 
Results 
In our case: 
Μ Τ 
ι and ι are measured in vivo 
Μ Τ 
Ρ and Ρ are determined with equation (13) from measurements 
m m 
of the sensor current in air 
Μ Τ d = 6 um and d = 13 μη. 
m ' m г 
Measurements performed in 5 newborns with the sensor heated to 
44 С gave the following results: 
ρ 
-^- = 8.2-10"6 to 17.7-10~б ml 0.,/cm2 · s-atm 
d . ¿ 
et 
This provides an estimate of the amount of 0 2 transported through 
the skin. It is of the same order of magnitude as the amount 
measured by Baumberger and Goodfriend (1951) who found a value 
of 25-10 ml 0,/cm -s-atm by heating the skin to 450C. 
For lack of specific data we use for the permeability of the 
avascular cutaneous tissue layer the value for connective tissue: 
P c t = 2.22-10~7 ml 02/cm .s.atm (at 440C) 
(Handbook of Respiration, 1958) 
Therefore: 
d = 125 pm to 270 μπι 
The magnitude of d . is consistent with the structure of the 
^ ct 
skin (§ 3.4.1) and confirms our previous assumption 
(d . < 400 um). 
et ' 
With equation (11) it follows that for various membranes: 
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(0.92 to 0.96) p^0 2 
(0.96 to 0.98) p^0 2 
(0.17 to 0.31) pMDj 
Comparative in-vivo measurements with sensors covered by Mylar 
membranes 6 pm and 12 jjm thick, respectively, showed that: 
cp0 2 (6 μα Mylar) = (0.99 + 0.06) cp0 2 (12 pn Mylar) 
wltre cpO, = cutaneously measured pO-, which corresponds to 
ρ От in the case of the model described above. 
me ¿ 
This ratio of 0.99 is not significantly different from that 
(0.97) derived from (19). 
3.4.6 
Discussion 
We have shown that when using a 6 pm Mylar membrane the current 
is limited by the diffusion of oxygen through the membrane and 
is a measure of the arterialized cutaneous pO-. A Mylar membrane 
of 6 pm thickness represents an optimum compromise between the 
two contradictory requirements of low permeability for oxygen 
and fast response time. With a 13 Jim Teflon membrane the sensor 
would be "faster" but would consume too much oxygen according 
to the values calculated above (19); with a 12 pm Mylar membrane 
it would be too "slow" (see § 3.5). 
These results also confirm our assumption concerning the arte-
nalization of the "capillarized" layer of the dermis (see 
above). Indeed, according to equation (19), by using a sensor 
heated to 44 С and covered by a 6 ^m Mylar membrane: 
ρ О. ( 6 um Mylar) = 
me 2 ' 
(19) ( P
m c
0 2 (12 pm Mylar) = 
ρ О- (13 um Teflon)= 
me 2 / 
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cp0_ = ρ 0-, = arterialized cutaneous tissue pO-,. 2 me 2 2 
In addition, as wo will show below (§4.2): 
cpOj = arterial blood рО^. 
Therefore, within the frame of the above mentioned approxi­
mations, arterialized cutaneous tissue p0 7 = arterial blood p0 7. 
It has to be realized, however, that in some situations, e.g., 
during marked peripheral vasoconstriction or in cases of edema 
neonatorum, the non-artenalized cutaneous layer may become 
much thicker than in the normal case described above. The 
equations (19) then are no longer valid and, in general, the 
cutaneous pO, does not correlate with the arterial pO-. 
3.5 
RESPONSE TIME AND FREQUENCY CHARACTERISTIC OF THE SENSOR 
3.5.1 
Response time of the sensor 
As mentioned previously (§ 3.4.4), according to equation (14), 
the current is limited by diffusion of oxygen through the 
membrane and is a measure of the pO, of tho art orjal ized 
cutaneous tissue if: 
d d . 
(15) F5 » ^ 
m et 
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This can be achieved by an increase of the membrane thickness, 
d , and/or by a reduction of the permeability coefficient of 
the membrane for oxygen, Ρ . Both measures have a detrimental 
effect on the response time of the sensor, which is given by 
(Schuier and Kreuzer, 1967): 
3d 3d 
90% 
η
2
 P. Л2 D. 
where Τη-. = time after which 90% of the final 
value is reached after application of a 
step change of pO-. 
о = oxygen solubility coefficient in the membrane. 
An additional parameter, ο , is at our disposal to reduce the 
response time of the sensor. However, the choice of the mem­
brane material is limited, which reduces the possibilities of 
altering this parameter. 
Thus one consequence of using a membrane of low permeability 
is that the response time of the sensor is relatively long. 
In our case, using a 6 pn Mylar membrane, T q is 18 to 40 s 
and T_,. is 9 to 14 s at 44 0C, where T_,
a
 = 2d 2/π 2 D . 73% /3% m m 
No exact mathematical expression for the response of the mem­
brane-covered sensor to a step increase of p0 2 can be derived. 
However, the following approximation may be calculated with the 
second law of Fick for the idealized case of a bare electrode in 
a convection-free solvent (Schuier, 1966; Wald et al., 1970): 
(20) i(t) i(t= « ) 1+2 £ ("D" exp 
n=l 
П7Г 
d D t m 
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Calculating i(t) for t 
П
2
 D. 
yields : 
П
2
 D 
0 . 3 i ( t = •: 
so that we may write 
d 2 
(21) -^— = Г 
π D 
30% time after which 30% of the final 
value is reached after application 
of a step change of pO . 
This provides an approximate method to determine the value of D 
π 
(Schuler, 1966). In our case, using a 6 pm Mylar membrane, we 
have T^na = 6 s at 44 C,and the oxygen diffusion coefficient 
in the membrane is: 
-9 2 
D = 6.1·10 cm /s (at 44 C) 
The measured and the calculated step response of the membrane-
covered sensor are shown in Tig. 8. 
50 60 0 5 10 20 30 40 
Fig. 8. Response to step increase of p0¿ 
Sensor heated to440C and coated with 6 Jim Mylar membrane 
— measured in gas phase 
calculated 
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time(s) 
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The reliability of correctly reproducing cpO- variations by 
sensors having different response times may be evaluated by 
determining the transfer function of the membrane, which allows 
the calculation of the frequency characteristics of various 
membranes. 
3.5.2 
Transfer function of the membrane 
The membrane is an element which allows to establish a relation­
ship between an input function x(t) and an output function y(t). 
Transient-response problems, as encountered here, are most easily 
treated by using the Laplace transform which is defined by: 
β 
L{f(t)} = F(s) = ( e" S t f(t)dt 
о 
where f(t) is a function of the real variable t and s is a 
complex variable. 
By using the Laplace transform the relationship between x(t) and 
y(t) then is given by: 
(22) Y(s) = K(s) X(s) 
wheieKis) = transfer function of the membrane. 
In case of a step response we have seen that the output function 
may be approximated by: 
CO 
(20) y(t) = 1+2 Y_ (-l)n exp 
n=l 
The calculation in Appendix 2 leads to the following expression 
for the Laplace transform of y(t): 
D t 
m 
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(23) Y(s) 
/ 2 ' 
/ s d / m / / D 
\l m 
2 
d 
m 
D 
m 
s i n h ν 
V 
/ 2 ' 
/sd / m / / D 
' m 
Since x(t) is a step function, its Laplace transform is: 
(24) X(s) = ì 
Therefore, by substituting equations (23) and (24) into 
equation (22) we obtain: 
(25) K(s) 
и 
/ m 
\ІЪ V m 
, d 2 
m 
D
m 
1 
s i n .h 
M 
W / m 
/"„, 
/sd 2 
/ m 
\ / D 
V m 
/ 
/ s i n h i / 
V 
1 
' s d 2 ' 
Ш 
D 
m 
3.5.3 
Frequency characteristic of the membrane 
The frequency characteristic of the membrane is given by: 
lui d 
m 
\/ D 
(26) К (Du) = m
;
 , = I К(з^)| exp Γ ](p(a))l 
/ m 
sinnv 
D 
m 
(Doetsch, 1967; Angot, 1965) 
55 
where: 
|K(J(D)I = amplitude-frequency characteristic of the membrane 
φ(ω) = phase-frequency characteristic of the membrane 
ω = 2Tf = angular frequency 
f = frequency 
If we assume that the input function, in our case the pO- at 
the membrane-skin interface, is given by: 
(27) ρ 0-(t) = A + В cos(ii)t) 
ms ¿ 
where A and В = constants 
the current of the membrane-covered sensor is then given by: 
2 4 π a F Ρ ρ -
(28) i ( t ) =
 2 2 4 0 0 - ρ I A + |K<jfo) | В cos U t +φ)\ 
m 
according to equations (13) , (22) and (26). 
The calculation in Appendix 3 leads to the following expressions 
for the amplitude- and phase-frequency characteristics of the 
membrane: 
D 
(29) |K(j
u
) | = • m 
d2 
m 
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tgh 
(30) 4>(ш) arc tg 
tgh 
2 D 
2 D 
tg 
tg 
/αϊ a 
I E 
2 D 
If we consider the simplified nodel described above (Fig. 7, 
§ 3.4.3) it is also possible to define a cutaneous tissue 
"membrane" and to calculate the frequency-characteristic of 
this "membrane". 
The frequency characteristics of various membranes are shown 
in Fig. 9. The values of D which have 
^ m 
|К(]ш)I and φ(ω) are listed in Table 2 
q been used to calculate 
Table 2: Oxygen diffusion coefficients (D ) at 44 С 
Τ = 440C 
Mylar 
Teflon 
Connective Tissue 
D (cm /s) 
m 
-6.1 -io - 9 
-6.2 ·10~7 
1.04-10-5 
Reference 
own measurements 
(calculated with equation (20)) 
Schuier (1966) 
(extrapolated value) 
Handbook of Respiration (1958) 
(extrapolated value) 
Thus Fig. 9 shows that the layer of cutaneous tissue acts as a 
filter for rapid ρΟτ fluctuations. The characteristic of this 
cutaneous filter is essentially similar to that of a "slow" 
membrane such as Mylar 6 μτη (curves for с and c' practically 
coincide). The information gained by using a "rapid" membrane 
such as Teflon 13 μπι is almost negligible as may be seen in 
Fig. 10 from comparative in-vivo measurements using sensors 
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Fig. э. Frequency characteristics with various membranes 
(a) 13 μ™ Teflon 
lb) 25μπι Teflon 
(c) 6 μπι Mylar 
(c)250μπι cutaneous tissue 
(o) estimates based on in vivo rneasurements 
covered by membranes of Mylar 6 pn and Teflon 13 pm. This type 
of recording allows to estimate the amplitude-frequency charac­
teristic of a 6 ym Mylar membrane, assuming that the attenuation 
and the phase shift of the signal by using a 13 pm Teflon mem­
brane is negligible in this frequency range (Fig. 9, curve (a)). 
These in-vivo estimates (Fig. 9, points (o)) roughly confirm 
the calculated curve (Fig. 9, curve (c)). 
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cpOj 
— / 
^ 
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Φ 
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л 
A time 
Fig. io. Response of cutaneous рОг to p a02 variations 
A increase of oxygen concentration in inspired air 
Sensor coated with a membrane of 
φ 6 μηι Mylar 
© 13 μπι Teflon 
Note: The in-vivo measurements described in sections 3.4.5 
and 3.5.3 have been performed at the Hospices Civils de 
Strasbourg, Service de Neonatologie (Dir.: Prof. Agr. 
D. Willard). 
3.6 
MONITOR CHARACTERISTICS 
The clinical trials reported in the next section (§ 4) have 
been performed with two types of devices: 
a laboratory prototype which consists of two channels for 
simultaneous measurements with two skin pO- sensors (Fig. 11) 
This device also allows to perform simultaneous measurements 
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Fig. 11. Laboratory prototype for simultaneous 
measurement with two sensors. 
Fig. 12. Oxygen Monitor 5300 
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with a skin p0, sensor and a catheter рСЦ sensor. The latter 
is described in Appendix 1. A built-in recorder allows the 
direct recording of both signals. 
- a commercially available one-channel device with built-in 
recorder (Fig. 12) (Oxygen Monitor 5300, developed by 
F. Hoffmann-La Roche & Co. Ltd., Bio-Electronics Department, 
Basel, Switzerland). 
Among the various control functions which appear on the front 
panel of both devices one can recognize the ZERO and CAL func­
tions. They allow to set the zero point and the gain during the 
calibration procedure. 
A block diagram of the electronic circuit is shown in Fig. 13. 
The BIAS (1) which ensures the operation of the sensor within 
its linear range is connected to block (2). The anode is con­
nected internally in the sensor to circuit ground. The current 
from the cathode, which is proportional to the pO-, is processed 
by blocks (2) - (7) before indication on the panel meter and 
recorder. Transformer (4) isolates the floating system from the 
grounded part of the circuitry. 
The thermistor, a temperature-sensing device, is part of the 
heating control system (10) - (12). The sensor's temperature 
is indicated on (15). The comparator (16) activates the 
heating logic (18) in case of a temperature excess or thermistor 
failure via the optical coupler (17). This logic then interrupts, 
via the optical coupler (13), the heating process after an alarm 
or if the heating is switched off manually. The pO- limit de­
tectors in the panel meter (8) are connected to the p0 2 alarm 
logic (19). 
SENSOR 
MAINS: 
FLOATING SYSTEM 
(NOT GROUNDEO) 
щшт 
φ £\> (S>iowl 0Ш 
ШТінс 
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ALARM 
RESET 
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иэ 
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д ^ ж ^ 
1 гешо е membrane retainer 
ring from sensor 
2 press sensor down into pre-
parator base as far as it will 
go 
3 apply one drop of sensor 
gel 
5 apply new membrane 
h withdraw one membrane 
7 insert membrane retainer ring 
in preparator top positioned 
as shown, repeat step 6 
6 press until initial resist­
ance is felt, then push down 
completely 
8 remove sensor as shown 
Fig. 14. Sensor preparation 
63 
Electrical power is transformer-coupled to the floating system 
by the DC converter (21) - (23). 
The recorder consists of the power supply (24) , the driver 
stage (25) and the electro-mechanical unit (9). 
3.7 
PREPARATION AND APPLICATION OF THE SENSOR 
The following description of the preparation and application 
of the sensor is mainly taken from the Operating Manual for the 
Oxygen Monitor 5 300. This standard procedure which is based on 
experience gained from the preliminary clinical trials (Eber­
hard et al., 1975 )has been used during the clinical trials 
to be reported in the next section (§ 4). 
Sensor By using the SENSOR PREPARATOR, a uniform 
Preparation sensor gel layer with reproducible thickness 
(Fig. 14 and is obtained. 
14 A) 1 Remove membrane retainer (snap-on) ring С 
from sensor, clean sensor surface and 
plunger surface with alcohol. 
2 Insert sensor В into preparator base A posi­
tioned as shown and press down as far as it 
will go. Wipe sensor surface once more with 
alcohol. 
3 Apply one drop of sensor gel (electrolyte) 
to the center of the sensor using the drip-
rod affixed to the bottle cap. 
4 Withdraw from membrane dispenser one pair 
of cardboard disks with a membrane in bet­
ween, rub disks between two fingers until 
the membrane becomes visible at the peri­
phery, do not touch membrane with fingers. 
5 Using tweezers place membrane centered on 
sensor surface. 
6 Place preparator top E onto base A, press 
button F with thumb and index finger until 
initial resistance is felt and then push 
down completely. 
7 Insert membrane retainer ring С into pre­
parator top E positioned as shown. 
Once more place preparator top E onto base 
A, then press button F with thumb and index 
finger down as described in 6. 
8 Remove the preparator top and take out the 
finished sensor by lifting the sensor neck 
G (not the cable) with the index finger. 
Inspect membrane surface for air bubbles or 
wrinkles {repeat entire procedure if any 
are seen). 
Remove excess sensor gel without touching 
membrane and connect sensor to oxygen moni­
tor. 
Clean preparator with alcohol or tap water 
if required. 
Connect the prepared sensor and attach it to 
the calibration chamber. Switch on the instru­
ment and the heating. Select the 100 mm Hg 
χ 2 range. Before proceeding to the next step, 
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allow 1-2 h until the recorder shows a 
distinct levelling-off of the indicated value. 
ZERO Calibration This should be performed during first-time 
without Sensor operation and repeated once every week. Allow 
at least one hour for the instrument to warm 
up. Disconnect the sensor from the instrument. 
Engage the χ 1 range and turn CAL clockwise 
to the stop. Adjust tne recorder read-out with 
the ZERO set-screw to zero. Reconnect the 
sensor and proceed. When calibrating with air 
the zero current with nitrogen described below 
will not exceed +4 mm Hg pO . 
ZERO Calibration If high precision at low p0 2 levels (< 50 mm 
with Hg) is desired ZERO calibration with nitrogen 
Nitrogen Gas gas is recommended. Let pure nitrogen gas 
bubble through the calibration chamber (half 
filled with distilled water) at a rate of 
approx. 250 ml/min. Turn the heating on. En­
gage the χ 1 range, and turn CAL to the 
clockwise stop. After the recorder read-out 
has stabilized, adjust it to zero with the 
ZERO set-screw. 
Air Calibration Attach sensor with heating "ON" to the cali­
bration chamber filled with distilled water 
at room temperature. Do not place chamber on­
to Monitor as the device may warm up. Wait 
until p07 reading has stabilized. This may 
take 1 to 2 hours if the sensor is freshly pre­
pared,and 5 to 15 minutes if the sensor has 
been used and needs to be recalibrated. For 
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calibration calculate p0_ according to: 
(31) p0 2 = 1.04 (pB - Рд 0) 0.21 mm Hg 
s 
where ρ = barometric pressure and ρ = 
В ПоО 
pressure of water vapor at room temperature. 
The correction factor 1.04 which has been 
estimated from in vitro measurements takes 
into account mainly the influence of the 
pressure of water vapor on the permeability 
coefficient of the membrane for oxygen (P ). 
m 
Example: ρ = 760 mm Hg, 
D 
pjj „ at 250C = 23.8 mm Hg. 
T h u s , p 0 7 = 1 6 0 . 8 nun Hg. 
Adjust the recorder read-out with the CAL knob 
to show the value calculated. 
Selection of For newborns, clinical trials have shown 
Measuring Site that the sites showing the best correlation 
between arterial and cutaneous oxygen 
partial pressure are on the left and the 
right side of the thorax, just below the cla­
vicles (Eberhard et al., 1975). 
Preparation of The skin should be shaved and cleaned at the 
Site application site, and greasy substances and 
loose particles should be removed. 
Application to The sensor is attached to the skin of the 
the Skin neonate by a double adhesive tape ring, 
as commonly used for e.c.g. electrodes (Fig. 
15). With this method, the pressure of the 
67 
Fig. 15. Two oxygen sensors attached 
to the thorax. 
sensor against the skin is extrememly small 
and does not cause compression of blood 
vessels underneath the sensor. 
In general, movements of the infant do not 
disturb the measurement. Only extremely strong 
movements may cause artefacts, particularly 
if the sensor is attached to one of the ex-
tremeties. Such artefacts, however, can be 
identified immediately in the recording. 
Measurement After the sensor has been attached to the 
skin, the pOp indication will slowly assume 
a steady value. The indication will stabilize 
as soon as the measuring site is warmed up and 
local arterialization is complete (provided 
the sensor has been thoroughly stabilized be-
fore the measurement). Induction time for 
arterialization is 10 to 20 minutes. 
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Calibration After removal from the patient, the sensor 
Check should be gently cleaned with an alcohol swab 
(do not press onto membrane). Check whether 
or not the sensor calibration has changed sig-
nificantly during utilization or removal (see 
calibration procedure). A change of less than 
5% over 8 hours is usual. If necessary, re-
calibrate before the next patient application 
(without re-preparing the sensor). Performing 
regular recalibrations permits continuous 
monitoring of a patient for 1-2 days. 
A proven routine is to prepare the sensor at 
the end of the day (if not used on a patient), 
connect it to the instrument and stabilize 
it during the night with the heating turned 
on. Air calibration may then be performed 
in the morning, immediately before utilization. 
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CLINICAL TRIALS 
4.1 
INTRODUCTION 
The results of comparative measurements between arterial and 
cutaneous pO„ and the examples of recordings reported below 
have kindly been made available to us by the following hospitals: 
Basel (Switzerland) 
Universitàts-Frauenklinik 
Drs. Jann, F.X., Hammacher, K. 
Bern (Switzerland) 
Universitàts-Frauenklinik 
Dr. Jann, F.X. 
Créteil (Paris, France) 
Centre Hospitalier Intercommunal. Service de 
Réanimation Infantile et de Néo-natologie 
Drs. Canet, J., Leraillez, J., Brioude, R., 
Gruson, S. 
Linz (Austria) 
Landes-Kinderkrankenhaus. Sauglingsabteilung 
Drs. Hohenauer, L., Hàckel, F., Haschke, F., 
Gerstl, W. 
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London (England) 
University College Hospital Medical School 
Drs. Soutter, L.P., Parker, D. 
Strasbourg (France) 
Hospices Civils de Strasbourg. Clinique Infantile. 
Service de Neonatologie 
Drs. Willard, D., Messer, J., Benoit, M. 
Zurich (Switzerland) 
Universitats-Frauenklinik. Abteilung fur 
Neonatologie 
Drs. Duc, G., Mieth, D. 
The cutaneous p0 2 measurements were performed mainly in newborns 
- with respiratory distress syndrome (RDS) 
- subject to oxygen therapy 
- placed in servo-controlled incubators and exposed to 
optimal and stable ambient temperature 
- without clinical hemodynamic anomaly syndrome 
The comparative measurements between arterial and cutaneously 
measured pO.(see § 4.2) were performed in high-risk newborns 
who had an umbilical artery catheter. As far as possible the 
blood samplings were made during periods when the cutaneous 
p0 2 recording was showing stable pO, values for several minutes. 
In this group of newborns the average birth weight was 2156 g 
(min. value: 810 g, max. value: 4280 g, standard deviation: 
848 g)» and the average number of gestational weeks was 34 
(min. value: 26, max. value: 41, standard deviation: 4 ) . 
The cutaneous pO^ values were determined on the subclavicular 
part of the thorax and the central arterial pO- values were 
determined in blood samples with a Blood Gas Analyzer. 
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4.2 
CORRELATION BETWEEN ARTERIAL AND CUTANEOUSLY MEASURED p0 2 
One of the primary goals of the clinical trials was the de­
termination of the correlation between arterial and cutaneous-
ly measured p0 2. 
It was assumed that within the population of the data a linear 
relation exists between the two variables (linear regression); 
for the statistical analysis of the data, the arterial blood 
pO, has been chosen as "independent" variable. The relation 
between arterial and cutaneously measured pO, may then be 
expressed by the following regression line (Crow et al., 1960): 
(32) срО, = a + b ρ 0 
a" 2 
where cpO- = cutaneously measured pOj, mm Hg (y axis) 
ρ 0, = arterial blood pO,, mm Hg (x axis) 
a = ordinate (y axis) intercept, mm Hg 
b = slope of the regression line 
The results of comparative measurements in 88 newborns (from 
6 hospitals) performed with a sensor heated to 44 С or 43 С 
are compiled in Tables 3 - 4 and Figs. 16 - 17. 
Table 3: Regression lines and correlation coefficient 
1 
2 
3 
Sensor 
temp. 
(0C) 
44 
44 
43 
Pa 0 2 
range 
(mm Hg) 
no limit. 
í 150 
no limit. 
N 
490 
414 
87 
Regression line 
cp02= 8.1 + 0.9 5 p a0 2 
cp02=20.0 + 0.64 P a0 2 
r 
0.934 
0.787 
Sy|x 
(mm Hg) 
19.9 
10.1 
20.0 
Fig. 
16 
17 
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where Ν = number of measurements 
r = correlation coefficient 
s = standard error of estimate, which is a measure of 
the scatter in the vertical (y) direction of 
the observed points about the regression line 
ρ 0_ axis 
^a 2 
cpOp axis 
Table 4: ρ 0_ and cpO, mean values 
1 
2 
3 
4 
5 
Sensor 
temp. 
(0C) 
44 
44 
44 
44 
43 
Pa 02 
range 
(mm Hg) 
no limit. 
< 50 
50 - 100 
>100 
no limit. 
N 
490 
53 
306 
131 
87 
X 
(mm Hg) 
95.1 
38.6 
74.2 
161.2 
84.5 
S
x 
(mm Hg) 
54.7 
8.4 
13.3 
56.0 
39.4 
У 
(mm Hg) 
98.5 
46.5 
78.0 
163.6 
74.2 
sy 
(mm Hg) 
55.7 
16.3 
14.8 
68.8 
32.2 
where χ = mean ρ 0., value 
a ¿. 
у = mean cpO, value 
s = standard deviation 
culaneously 
measured 
cpO?(mmHg) 
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At 44 С the correlation between arterial and cutaneously mea­
sured pO, is significant (r = 0.934) and the regression line 
(cp02 = 8.1 + 0.95 P.O.) does not deviate significantly from the 
identity line, ]ust as the mean values of ρ О. and cpO? are very 
similar (Table 4, line 1). Without detailed statistical analysis 
one can also easily see that in hypoxia (p 0- < 50 mm Hg), 
normoxia (50 mm Hg ^ ρ 0- < 100 mm Hg), and hyperoxia (p 0, > 
100 mm Hg) the mean values of ρ 0 and cpO^ do not differ sig­
nificantly (Table 4, lines 2 - 4 ) . 
At 43 С the correlation is poor (r = 0.787) and the regression 
line (cpO_ = 20.0 + 0.64 ρ О,) deviates significantly from the 
¿. a ζ 
identity line. The mean value of cpO. is lower now (approx. 
12 %) than the mean value of ρ 0 2 (Table 4, line 5). 
At lower sensor temperatures the correlation was found to be 
even poorer (r < 0.74 at 42 C) by Due et al. (1975), Versmold 
et al. (1975), and Haschke et al. (1976). 
With the sensor heated to 44 C, the standard error of estimate 
is relatively high (s = 20 mm Hg) if one considers the full J
 ^ y| χ 
ρ О, range (Table 3, line 1). However, in practice this error 
cannot be attributed solely to the cutaneous pO- although the 
arterial pO- has been chosen as the "independent" variable here. 
As mentioned previously (§ 2.4.1) considerable errors may be 
incurred in the determination of the pO- of the arterial blood 
samples with Blood Gas Analyzers. The sampling technique and 
the time-lag between sampling and analysis are among the most 
important sources of error in the routine determination of ρ 0, 
(Rhodes and Moser, 1966; Severinghaus and Bradley, 1969; Good, 
1972). It is therefore rather difficult to estimate the total 
error related to the determination of ρ 0_ (the error related 
a ¿. 
to the Analyzer itself is approximatively + 2 mm Hg in the 
pO, range О to 200 mm Hg according to various manufacturers). 
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In order to obtain an order of magnitude of this measuring 
error, which may vary from hospital to hospital, we performed 
in one hospital comparative measurements (blind test) with 
two different Blood Gas Analyzers, one being routinely used 
by the hospital personnel, the other being used by a skilled 
technician who measured the pO_ of the samples immediately 
after collection. The following results were obtained: number 
of measurements: 39, ρ 0 range: 0 to 300 mm Hg, correlation 
coefficient: 0.997, standard error of estimate: 6 mm Hg. We 
also noted that the ρ 0_ values determined routinely by the 
hospital personnel (Γρ 0-1 ) were systematically closer to 
the pO- values in air than the ρ 0- values determined by the 
Δ a ¿. 
skilled technician (Γρ O-l ), which was confirmed by the 
regression line: Γρ O-l = 20.9 + 0.85 Гр 0 1 . This contami­
nation of arterial blood samples by air may be important, 
especially at high ρ О, values (ρ 0„ > 150 mm Hg). This mainly 
explains the scattering of the points (see Fig. 16) in this 
pOp range, as well as the fact that the standard error of 
estimate is considerably higher when the full ρ 0 7 range 
(s = 20 mm Hg) is considered than when the ρ О range is 
у I χ a ¿ 
limited to 150 mm Hg (s = 10 mm Hg) (Table 3, lines 1 - 2). 
However, this scattering of the points at high p0_ values, 
whatever the reasons, is of little practical significance in 
clinical medicine. Indeed a precise ρ О, determination is not 
required in this Ρ,Ο, range, since the main concern of the 
clinician is to monitor the oxygenation in the newborn in order 
to avoid the risks related to hyperoxia (see § 1.3). 
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4.3 
APPLICATIONS TO MONITORING 
To illustrate the performance and applicability of the method, 
a few typical curves are shown below (Figs. 18 - 24). These 
recordings were performed in the following hospitals: 
- Universitats-Frauenklinik, Basel. Figs. 20, 23 and 24. 
- Centre Hospitalier Intercommunal, Créteil. Figs. 21 and 22. 
- Hospices Civils, Strasbourg. Figs. 18 and 19. 
The skin pO, sensor was positioned on the subclavicular part 
of the thorax (see § 3.7). 
Fig. 18. Response of cutaneous pO, to change of oxygen concen-
tration in inspired air. 
During spontaneous breathing of room air, the cuta-
neous p0? varies between 40 and 44 mm Hg. At time A, 
pure oxygen is administered (hyperoxia test) for appro-
ximatively 1 min (A-B). After an induction time of 
about 20 s, the cutaneous pO, increases rapidly and 
then returns to its initial level. 
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A time в \_"t 
Fig. 19. Change of oxygen concentration in inspired air due to 
opening the windows of the incubator. 
The newborn is spontaneously breathing air enriched 
with oxygen (F 0- = 35%). At time A, the windows of 
the incubator are opened. The cutaneous pO, decreases 
from 60/62 mm Hg to 37 mm Hg. After closing the windows 
(time B) the pO., slowly returns to the initial level. 
time \"< · 
Fig. 20. Apnea 
After spontaneous inhalation of 26% oxygen, transient 
cessation of breathing occurred and was not immedia­
tely noticed by the nurse. The cutaneous pO. decreases 
from 60 mm Hg to about 20 mm Hg within 3 m m . After 
resumption of breathing, the pO, slowly returns to 
normal values. 
А В time 
Interruption of artificial respiration during intra­
tracheal suction (newborn with respiratory distress 
syndrome). 
At time A, the respirator is disconnected. The cuta­
neous p0 2 decreases from 54/58 mm Hg to values below 
20 mm Hg within 3 min. After resumption of artificial 
respiration (time Β), the pO- returns to normal level 
which is higher than before time A. 
V А В С DE F time G 
Change in the mode of ventilation in a newborn with 
respiratory distress syndrome. 
During spontaneous respiration of air enriched with 
oxygen by means of a mask, normal p0 2 levels (Α-B) can 
be obtained only with a very high F 0 (90% 0,). It was 
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then decided to change the mode of ventilation. The 
hood was taken off (B) and the newborn was prepared for 
the intubation procedure. The cutaneous pO, decreases 
from about 90 mm Hg to values below 40 mm Hg within 
2.5 min (B-C). Prior to intubation the newborn re-
ceives oxygen for a short period of time (C-D) by means 
of a facial mask. After the intubation procedure (E-F) 
the nasotracheal tube is connected to the respirator 
(F) (mode of ventilation: P.E.E.P., + 2 cm H_0) and 
the cutaneous p07 returns to normal levels (F-G). 
Fig. 23. Simultaneous recording of blood pressure, heart rate 
and cutaneous p02. 
The pO- scale has been expanded to obtain a better re-
solution of the fluctuations of the signal. One recog-
nizes two spontaneous drops of heart rate and increases 
of blood pressure (caused by brief apnea), each fol-
lowed by a significant decrease of pO,. The time delay 
between the fall in heart rate and the decrease of 
pO-, is approximately 20 s. 
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Fig. 24. Simultaneous measurement of arterial and cutaneous 
pO- in a one-day-old newborn with respiratory distress 
syndrome. 
1. Skin p0_ sensor. 
2. Catheter-tip pO- sensor, implanted in the aorta 
descendens through the umbilical artery. 
At time A the respirator is disconnected for intra­
tracheal suction. The shift of the time axis of the 
two channels is one-fifth of one scale unit (corre­
sponding to 12 s) . 
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5. 
DISCUSSION AND CONCLUSION 
After the introduction of the cutaneous measurement by direct-
ly heated oxygen sensors (Eberhard et al., 1970, 1972; Huch et 
al., 1972), the clinical applications of this new method have 
been extensively investigated and described in numerous papers 
(Jann and Eberhard, 1974; Jann et al., 1974; Huch et al., 1974, 
1975; Eberhard et al., 1975; Fenner et al., 1975; Swanström et 
al., 1975; Canet et al., 1976; Eberhard, 1976; Haschke et al., 
1976; Hohenauer et al., 1976; Mieth et al., 1976; Peabody et 
al., 1976; Willard et al., 1976). 
Although the method has proven to be of considerable interest 
for neonatal monitoring, its limitations have not been fully 
explored until now, and the question arises, what are the cri-
teria for the assessment of the reliability of cutaneous pO-
measurement. Indeed various factors may affect the cutaneous 
pO- value. The most important factors are listed in Table 5, 
subdivided into physiological, methodological and technical 
factors. 
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Table 5: Factors affecting cutaneous pO- value 
Physiological 
parameters 
Methodological 
parameters 
Technical 
factors 
and 
sources of 
failure 
- arterial p0_ 
- circulatory condition 
- peripheral blood perfusion 
- skin properties 
- anatomical anomalies (e.g. shunts) 
- oxygen consumption at cathode 
- response time of pO, sensor 
- temperature profile generated in tissue 
- changes of physiological conditions in-
duced by the application of heat 
- drift of sensor current 
- accuracy of calibration 
- failures in preparation or application 
of sensor 
- tightness of seal against environment 
- movement artefacts 
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The cutaneous рО^ does not only reflect the arterial p0_ but 
also depends on a variety of other physiological parameters, 
some of them being listed in the first group of the table. 
Essentially this means that this method should not be consi­
dered to be a "transcutaneous" measurement of arterial pO-, 
since the measured parameter is primarily the cutaneous pO, 
value which correlates with the arterial pO, under certain 
physiological conditions. In the second group those factors 
are listed which can be attributed to the method per se, i.e., 
all aspects related to the application of a heated oxygen 
sensor to the skin. Included are also changes of physiological 
conditions which are induced by the application of heat, such 
as active vasodilatation of the cutaneous vessels, increase 
of the permeability coefficient of the cutaneous tissue for 
oxygen, and reversible and irreversible reactions of the cuta­
neous tissue to heat (see § 3.4.2). The third group comprises 
purely technical parameters related to Clark-type oxygen sensors 
and potential sources of failures which may occur during the 
practical use of the technique (see § 3.3 and § 3.7). Of course, 
these last factors depend not only on the technique but also 
on the way the technique is used. 
Within the frame of this paper two methodological criteria for 
the assessment of the reliability of cutaneous p0_ monitoring 
have been described extensively. These are the oxygen profile 
in the vicinity of the cathode (§ 3.4) and the response time 
of the sensor (§ 3.5). 
We have seen that in our oxygen sensor a large cathode (dia­
meter 4 mm) is used which allows to obtain an average pO, value 
over a sufficiently large skin area. The permeability of the 
membrane for oxygen has to be kept low to avoid a disturbance of 
the oxygen profile in the cutaneous tissue due to the oxygen 
consumption of the sensor. A simplified model has been studied 
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(§ 3.4.3), and we have shown that by using a 6 μιη Mylar membrane 
the sensor current is limited by diffusion of oxygen through 
the membrane and is a measure of the arterialized cutaneous 
tissue pO-. However, as previously mentioned (§ 3.4.6), it has 
to be realized that in some situations, e.g., during marked 
peripheral vasoconstriction, the cutaneous pO, does no longer 
correlate with arterial p0_. To illustrate this limitation of 
the method, the following results of comparative measurements 
performed in a newborn in shock (systolic arterial blood 
pressure: 20 mm Hg and blood pH: 6.90) may be given: 
cutaneous p0 2 (mm Hg) : 64 30 20 
arterial pO- (mm Hg) : 102 69 46 
Here the cpO, values are much lower than the ρ 0 values. These ¿· a ¿ 
three correlation points deviate significantly from the re-
gression line obtained with sensors heated to 44 С in the usual 
situation with adequate vasodilatation (Fig. 16). 
As we have seen, one implication of using a membrane of low 
permeability is that the response time of the sensor is relati­
vely long (§ 3.5.1). In our case, with a 6 μιη Mylar membrane 
the time in which two thirds of the final value are reached is 
approximatively IO sec, and 90% of the final value are reached 
in approximatively 30 sec. The reliability of correctly repro­
ducing cutaneous p0_ variations by sensors having different 
response times has been evaluated by determining the transfer 
function of the membrane which allows the calculation of the 
frequency characteristics of various membranes (§ 3.5.3). In 
this manner we have been able to show that the layer of cuta­
neous tissue acts as a filter for rapid p0_ fluctuations. The 
characteristic of this cutaneous filter is essentially similar 
to that of a "slow" membrane such as Mylar 6 μιη. It may be de­
duced from these findings that the pO fluctuations are already 
damped by diffusion processes through the cutaneous tissue to 
such an extent that the information gained by using a "rapid" 
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membrane such as Teflon 13 pm is almost negligible, as we have 
seen from comparative in-vivo measurements performed simulta­
neously with "slow" and "fast" membranes. In any case this 
attenuation and phase shift of the pO- signal, which occurs 
only at relatively high frequencies, has no real significance 
in clinical medicine. 
After having described these two methodological factors we 
have seen that according to clinical trials performed with 
sensors heated to different temperatures, the percentage of the 
cases in which a significant correlation between arterial pO. 
and cutaneously measured p0 ? is obtained increases with tempe­
rature (§ 4.2). In 490 comparative measurements in newborns 
performed with sensors heated to 44 С the correlation between 
these two parameters is significant (correlation coefficient: 
0.934) which means that the capillanzed layer of the dermis 
may be effectively arterialized at this temperature. On the 
other hand the correlation is relatively poor at 43 С (r = 0.787). 
At a sensor temperature of 44 C, corresponding to approx. 43 С 
measured at the skin surface, the sensor will cause a slight 
skin irritation (erythema) consisting of a local reddening which 
disappears, in general, after a few days. In a few instances, a 
second-degree burn with formation of a blister (phlyctena) has 
been observed. The probability of such an event appears to de­
pend not only on the sensor temperature and the time of exposure 
of the skin but also on several physiological parameters, such 
as local tissue perfusion and body temperature. In the case of 
newborns, a change of the sensor site every 4 hours has been 
shown to eliminate the risk of blister formation almost entirely. 
In contrast the temperature of 43 С has been found to be tole­
rated well by the skin over longer periods of time (up to 24 
hours). Oversensitivity or burns have never been observed at 
this temperature. 
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In view of the scatter in the relationship between arterial and 
cutaneous p0_ obtained with sensors heated to 44 С (Fig. 16) the 
cutaneously measured value provides a qualitative estimate of 
the individual arterial pO,,. Therefore, as mentioned above, the 
cutaneous p0 2 measurement technique cannot be regarded as a 
substitute for conventional blood gas analysis via sampling of 
arterial blood because in some situations, e.g., during marked 
peripheral vasoconstriction, the cutaneous pO., does no longer 
correlate with arterial blood pO . 
Cutaneous p 0 2 measurement is a supplemental technique affording 
the possibility of continuously monitoring clinically signifi­
cant changes in the oxygenation state of the newborn, changes 
which may go unnoticed in the time interval between blood 
sample analyses (see § 4.3). This non-invasive monitoring is 
of particular value in following up the immediate effect of 
therapy, e.g., changes in the mode of ventilation, shock treat­
ment, bicarbonate infusion, intratracheal suction or clinical 
routine measurements. This short-term information on trends 
permits a qualitative assessment of the effect of the therapy. 
In general, it allows a more rapid detection of hypoxia or 
hyperoxia than arterial sampling. Moreover, the cutaneous pO-
measurement may be useful in determining the timing of arterial 
blood sampling. This may considerably reduce the frequency of 
sampling, avoiding excessive blood loss for the newborn. 
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SUMMARY 
Monitoring of the arterial pO, during oxygen therapy in the 
newborn is of considerable importance in preventing the dele-
terious effects of both hypo- and hyperoxygenation, such as 
damage to brain, eyes and lungs. At present, the only re-
liable method for checking the oxygenation of the newborn is to 
periodically withdraw arterial blood, either from an umbilical 
artery catheter or by puncturing the radial, temporal or bra-
chial arteries. Besides the fact that blood sampling from arte-
ries in newborns is cumbersome, often subject to errors and not 
without hazard, it gives information that is relevant only for 
the time of sampling. A continuous measurement would be prefe-
rable since pathological changes and toxic levels of pO, can be 
recognized immediately. Furthermore, information of prognostic 
value may be obtained from observing the trend of the oxygenation 
of the newborn. 
A non-invasive method for the continuous oxygen monitoring in 
the newborn is described. The oxygen partial pressure is measu-
red cutaneously by a specially developed Clark-type oxygen sen-
sor attached to the surface of the skin. By directly heating the 
sensor to a constant temperature, local arterialization is achie-
ved in the cutaneous tissue underneath the sensor. Methodological 
criteria for the assessment of the reliability of cutaneous pO, 
monitoring are discussed. Particular consideration is given to 
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the oxygen profile in the vicinity of the cathode and to the 
response time of the sensor. 
The рСЦ profile in the vicinity of a cathode with a large sur­
face area is calculated. The disturbance of the oxygen consump­
tion at the cathode is negligible if a membrane of sufficiently 
low oxygen permeability (such as Mylar 6 tun) is used. 
The reliability of the reproduction of p0 2 variations by sensors 
having different response times is evaluated by determining the 
transfer function of the membrane which allows the calculation 
of the frequency characteristics of various membranes. The cu­
taneous tissue layer acts as a filter for rapid p0_ fluctuations. 
The characteristic of this cutaneous filter is essentially si­
milar to that of a "slow" membrane such as Mylar 6 um. The in­
formation gained by using a "rapid" membrane such as Teflon 13 um 
is almost negligible. The data obtained are compared with results 
of clinical studies. 
According to clinical trials performed with sensors heated to 
different temperatures, the percentage of cases in which a signi­
ficant correlation between arterial pO, and cutaneously measured 
pOj is obtained increases with temperature. The results of 4 90 
comparative measurements in newborns performed with sensors hea­
ted to 44 С show that the correlation between these two parameters 
is significant (correlation coefficient: 0.934). However, the cu­
taneous pOy measurement technique cannot be considered to be a full 
substitute for arterial blood pO- analysis. Its value lies in the 
continuity of the measurement, which allows the immediate detection 
of changes of the oxygenation of the newborn and facilitates the 
control of oxygen therapy. Furthermore, information of prognostic 
value may be obtained from observing the trend of the cutaneously 
determined p0 ?. 
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UN CAPTEUR JETABLE POUR LA SURVEILLANCE CONTINUE DE LA PRESSION PARTIELLE D'OXYGENE 
INTRAVASCULAIRE 
A DISPOSABLE CATHETER SENSOR FOR THE CONTINUOUS MONITORING OF INTRAVASCULAR OXYGEN 
TENSION 
P. Eberhard 
Bioelectronics Department 
F. Hoffmann-La Roche & Co. , 
Basel, Switzerland 
- L'utilisation de capteurs mniaturisés du type Clark a rendu possible 
la surveillance continue de la pression partielle d'oxygène intra-
vasculaire. Pour l'utilisation de routine en clinique un capteur à 
oxygène doit satisfaire aux exigences suivantes: il doit être à usage 
unique, facile à manier, quantitatif et stable pendant une période de 
plusieurs jours sans nécessiter de recalibration. Dans cet article 
sont présentés les caractéristiques in vitro et les résultats des 
premiers essais cliniques obtenus avec un nouveau type de capteur ré-
pondant pour l'essentiel à ces exigences. 
Abstracts - The use of indwelling Clark-type sensors has made possible the con-
tinuous monitoring of the intravascular oxygen tension. An oxygen 
catheter sensor for clinical routine use should fulfill the following 
requirements: It should be disposable, easy to handle, quantitative and 
stable over a time of several days without the need for recalibration. 
This paper reports in vitro characteristics and results of first clini-
cal trials obtained with a new type of sensor, which essentially meets 
these conditions. 
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TENSION 
Oxygen partial pressure in blood is usually determined in vitro by analyzing dis­
crete blood samples. However, in many cases, especially during intensive care of 
patients, a continuous measurement of pO^ is desirable. This allows not only the 
immediate recognition of pathological p02 changes but also affords an opportunity 
to observe the trend of changes in the oxygenation of the patient and to start 
therapy promptly when needed. 
In recent years it has become possible to measure the intravascular oxygen partial 
pressure continuously with the help of miniaturized sensors based on mass spectro-
metric or amperometriс principles (1-5) . Mass spectrometry has 1_ho advantage of 
permitting the simultaneous determination of О-, СО-, and other gases} however, this 
method appears to be too cumbersome for routine use. Continuous non-invasive p0_ 
monitoring by use of a heated Clark-typo (amperometric) sensor attached to the sur­
face of the skin has also been described (6,7). Under certain conditions this method 
allows an approximate determination of arterial PO2
r
 but it cannot be regarded as 
a full substitute for p02 analysis via sampling of arterial blood. The miniaturi­
zation of the Clark-type sensor for continuous in vivo measurement was first des­
cribed by Kreuzer and Nessler (8). The design of this sensor is as follows A pla­
tinum cathode is surrounded by a silver anode, a teflon membrane is stretched over 
the tip of the sensor and held by a silver ring, the diameter of the sensor is 
approximately 2 mm (9). Similar constructions have been described by several authors 
(10-13). However, probably because of the complexity of the designs and of the dif­
ficulties inherent in their practical use, these sensors have so far not been wide­
ly accepted for clinical routine application. 
An oxygen catheter sensor for clinical routine use should fulfill the following re­
quirements: It should be disposable, easy to handle, quantitative and stable over a 
time of several days without the need for recalibration. This paper reports results 
obtained with a new type of sensor, which essentially meets these conditions. 
The design of the sensor has boon previously described (14). It is based on the 
principle of Clark. The cathode ana the anode wires are placed in parallel in a me­
dical grade polymer tubing which covers the sensor entirely and acts as an oxygen-
permeable, hydrophobic membrane. The permeability of the membrane for oxygen is kept 
low to avoid a disturbance of the oxygen profile m the surrounding medium as a 
result of the oxygen consumption of the sensor. A particular advantage of this con­
figuration is that the sensor is not very sensitive to fibrin deposition, which is a 
prerequisite of long term stability. 
The external diameter of the sensor is 0.8 mm. It can be introduced into the vessel 
directly or via a previously placed guide catheter. 
The polarogram and the calibration line of the p02 sensor in the gas phase at 37 С 
are shown in Fig. 1. The oxygen reduction plateau is broad and horizontal over a 
wide voltage range (approx. 500 -nV) at levels of oxygen between О and 100i>. The cali­
bration line is linear from О to 100% 0„ and the zero current equivalent is 1 mm Hg. 
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the gas phase at 37 C. 
The interference by ССЦ is negligible. The temperature dependency of the sensor 
current determined in water saturated with air is 4%/ С at 37 C. Measurements in 
water and in blood at 37 С have shown that the sensor current is insensitive to 
pressure changes in the range between 50 to 250 mm Hg at a pulse rate of 100/s. The 
response time of the sensor to reach 95% of the steady state value, TQ,.., I S 60 sec. 
The flow dependency of the pO sensor in water at 37 С is shown in Fig. 2. The ratio 
between the current measured in water at a certain velocity, I , and the current in 
the gas phase, I , is still 99% at a velocity of the surrounding medium of 5 cm/s. 
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Fig. 2 Flow dependency of pO catheter sensor in water at 37 C. 
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Animal trials hdvo been performed in non-heparini^ed cats (14). Comparative measure-
montb between the ρΟ
Ί
 аіиеь obtained by sam[ ling blood from a centrally located 
catheter and those obtained with the p02 sensor placed in the femoral artery have 
shown that t"he sensor is stable and linear over several days. The fibrin deposition 
on the sensor surface which we observed at the end of the tests was negligible. 
The end calibration performed in vitro after the in vivo measurement did not change 
sigr.ificantly from the initial in vitro calibration. 
First clinical trials have been performed in the intensivo care unit of the Depart-
nent of Internal Medid-ne of the Zurich University (E. Busser, R Schibli, P.C. Bau­
mann). The sensor was calibrated before and after each implantation in vitro at 370C. 
It was therefore possible to determine the in vivo stability of the sensor over seve­
ral days (up to 7 days). On average, the drift of the current was found to be below 
1.5 %/24 hours. 
Fig. 3 Relationship between the p02 values determined in 
blood samples with the blooa jas analyzer aid 
those obtained with Lhe pCb cathtter. 
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After gas sterilization and in vitro calibration the sensor was introduced by using 
a Y-shaped connector (allowing simultaneous blood sampling through the same needle) 
from the inguinal artery into the aorta or from the cubital artery into the subcla­
vian artery. The precise location of the sensor was determined by X-ray. Comparative 
measurements between the pC^ values determined discontinuously in vitro with a blood 
gas analyzer (IL 213) and those obtained with the p02 sensor were performed. The re­
sults of 41 measurements are compiled in Fig. 3. 
It has been assumed that, within the population of the data, a linear relation exists 
between the two variables (linear regression). The correlation coefficient is 0.99Θ. 
The regression coefficients of the relation y = b + b-, x, where χ is the value ob­
tained with the catheter and y that obtained with the blood gas analyzer are: 
b = 5.6 mm Hg with a standard error of 1.5 mm Ilg and b^ ^ = 0.99 with a standard error 
of O.Ol. The standard error of estimate is 5.5 mm Hg. Fig. 3 shows the true regression 
line and the 95% prediction interval limits for individual values of arterial pC^. 
The accuracy and stability of the pC^ catheter sensor allows the continuous pC^ moni­
toring over several days. The small dimensions of the catheter permit not only long-
term intra-artenal measurements but also central venous measurements via previously 
placed catheters. 
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APPENDIX 2 
LAPLACE TRANSFORM OF THE FUNCTION y(t) 
y(t) is given by: 
(20) y(t) = 1 + 2 Y_ (-1)" exp 
n=l d 1 m m 
S u b s t i t u t i n g - f t = В i n t o e q u a t i o n (20) y i e l d s : 
d^ 
m 
y<¡3) = 1 + 2 Y_ ( - l ) n exp ί- η27Γ2β) 
and according to Doetsch (1967) (p. 254) : 
ш =03(1/2,6) = - ^ Σ exp ( - - í a i p i l ) 
\/л: 0 n=-· \ B / 
Ліеге 0, (1/2, S) = Theta function 
The Laplace transform of y(β) is given by: 
L{y(ß)} 
>/s^  sinh N/S"1 
(Doetsch, 1967, Formula 184, p. 240) 
substituting β = — t we obtain: 
d 
m 
L { y ( t ) } = Y(s) = m m 
v/s d2/D s i n h \/s d2/D V m m V m m 
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APPENDIX 3 
AMPLITUDE- AND PHASE-FREQUENCY CHARACTERISTICS OF THE MEMBRANE 
The frequency characteristic of the membrane is given by: 
lm d 
(26) Κ(]ω) 
3 ω d 
sinh 
S u b s t i t u t i n g \ / TT1 = Y i n t o e q u a t i o n (26) 
m 
we o b t a i n : 
K ( ; J Ù ! ) 
ι/Τω1 
s i n h ( γί/ΐϋ1) 
then wi th / 7 " = — ( l + j ) 
Κ(]ω) = 
Y V T ( і + з ) 
sinh Y\/f ( 1 + з ' 
| k (]ш) | e x p Γ ](^(u.)J 
A 3 . 1 
Amplitude-frequency characteristic of the membrane (|K(ju3)|j 
|Κ(3ω)| V i 1(1 + 3)1 
;inh [y\/f (1+3)] 
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then with 
I 2 2 ' 
|sinh(x+]y)| = \J sinh χ + sin y 
. γ \Λ7 |κ(]ω) I 
yi^TpfjTT^pyj 
and with γ 
|Κ(]ω) I = 
/ я 2 / н 2 
sinh, /35- + sin. / jo-
m V m 
A 3.2 
Phase-frequency characteristic of the membrane [ </>(ω)] 
With sinh (x+]y) = sinh χ cos y + 3 cosh χ sin y 
and γ ^ | = 6 
К(]ш) is given by: 
Κ(:ω) 0(1+3) 
sinh * cos 6 + ] cosh л sin б 
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then 
tgVXu..) = tg - arc tg (coth 6 tg δ] 
tq<pU 
tg j - tg [arc tg (coth δ tg 6 )] 
1 + tg j tg [are tg {coth 6 tg δ)] 
tg</5(<D) 
1 - coth δ tg i _ cot fi - coth δ _ tqh δ - tg δ 
1 + coth δ tg δ cot δ + coth δ tgh δ + tg δ 
and with δ = 
φ(ω) = arc tg 
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STELLINGEN 
1. By directly heating to 44 С a Clark-type oxygen sensor 
attached to the surface of the skin, the capillarized layer 
of the dermis underneath the sensor may be arterialized 
effectively. 
This thesis, § 5. 
2. According to clinical trials performed with sensors heated 
to different temperatures, the percentage of cases in which 
a significant correlation between arterial pO- and cutaneous-
ly measured pO, is obtained increases with temperature. 
This thesis, § 4.2. 
3. When using a 6 pm Mylar membrane the sensor current is limi­
ted by the diffusion of oxygen through the membrane and is a 
measure of the arterialized cutaneous tissue p02. 
This thesis, § 3.4. 
4. The frequency characteristics of the layer of cutaneous 
tissue is essentially similar to that of a "slow" membrane 
such as Mylar 6 μπι. 
This thesis, § 3.5. 
5. Despite the fact that the total oxygen consumption of a 
large-size cathode (e.g., 4 mm diameter, covered by a 6 μια 
Mylar membrane) is much higher than that of a microcathode 
(e.g., 15 pm diameter, covered by a 13 ym Teflon membrane), 
the oxygen consumption per surface area of the cathode, i.e., 
the density of oxygen flux to the cathode, is two orders of 
magnitude higher in the case of a microcathode. 
This thesis, § 3.3. 
6. Optimal measuring conditions may be achieved if the surface 
areas of the thermally conductive parts of the cutaneous oxy­
gen sensor are large and kept at the same temperature. 
Mmdt, W. , Eberhard, P., Hammacher, K. : Reliability 
of cutaneous pOp monitoring of newborns. Methodo­
logical aspects. Proc. 5th European Congress of 
Perinatal Medicine, Uppsala (1976) 36. 
7. According to Huch et al. (1975) the heating energy which is 
required to keep the sensor temperature at a constant level 
against the cooling effect of the flowing blood is a re­
liable indicator of the local blood perfusion. 
This is not true when the sensor is not isolated from the 
fluctuations of the ambient temperature. 
Huch, Α., Lubbers, D.W., Huch, R.: Der periphere 
Perfusionsdruck: Eine neue nicht-invasive Mess­
grosse zur KreislaufÜberwachung von Patienten. 
Anaesthesist, 24 (1975) 39-40. 
8. Anesthetics such as halothane and N-0 may be electrochemi-
cally reduced at the cathode of a Clark-type oxygen sensor, 
leading to erroneous p07 measurements. 
Sevennghaus, J.W., Weiskopf, R.B., Nishimura, Μ. , 
Bradley, A.F.: Oxygen electrode errors due to Po­
larographie reduction of halothane. J. Appi. 
Physiol., 21' * < 1 9 7 1) 640-642. 
9. The oxidation of hydrogen at platinum electrodes is inhibi­
ted by traces of silver. 
Eberhard, P., Mindt, W.: Inhibition of hydrogen 
oxidation at Pt-electrodes by adsorbed silver. 
In: Oxygen Supply. Kessler M. et al. (eds.) Urban 
und Schwar7enberg, München, Berlin und Wien (1973) 
115-116. 
10. It is much easier to build one engineering prototype than to 
manufacture a series of identical instruments. 
Eberhard, P. Personnel experience. 
11. Par liberté, j'entends le triomphe de l'individualité tant 
sur l'autorité qui voudrait gouverner par le despotisme que 
sur les masses qui réclament le droit d'asservir la minorité 
à la majorité. 
Benjamin Constant 
Mélanges de littérature et de politique (1829) . 
12. L'art obéit à sa logique particulière, d'autant plus impré-
visible que la découvrir est très précisément la fonction du 
génie. 
André Malraux 
L'héritage culturel (1936). 
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